KR101249711B1 - 1-클로로-4-(β-Ｄ-글루코피라노스-1-일)-2-［4-((Ｓ)-테트라하이드로푸란-3-일옥시)-벤질］-벤젠의 결정형, 이의 제조방법 및 약제 제조를 위한 이의 용도 - Google Patents

1-클로로-4-(β-Ｄ-글루코피라노스-1-일)-2-［4-((Ｓ)-테트라하이드로푸란-3-일옥시)-벤질］-벤젠의 결정형, 이의 제조방법 및 약제 제조를 위한 이의 용도 Download PDF

Info

Publication number
KR101249711B1
KR101249711B1 KR1020077028240A KR20077028240A KR101249711B1 KR 101249711 B1 KR101249711 B1 KR 101249711B1 KR 1020077028240 A KR1020077028240 A KR 1020077028240A KR 20077028240 A KR20077028240 A KR 20077028240A KR 101249711 B1 KR101249711 B1 KR 101249711B1
Authority
KR
South Korea
Prior art keywords
crystalline form
solution
chloro
benzyl
benzene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
KR1020077028240A
Other languages
English (en)
Korean (ko)
Other versions
KR20080015424A (ko
Inventor
맛티아스 에카르트
프랑크 히멜스바흐
산드라 직크
마르틴 쉴레
한스 위르겐 마르틴
Original Assignee
베링거 인겔하임 인터내셔날 게엠베하
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36593171&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR101249711(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 베링거 인겔하임 인터내셔날 게엠베하 filed Critical 베링거 인겔하임 인터내셔날 게엠베하
Publication of KR20080015424A publication Critical patent/KR20080015424A/ko
Application granted granted Critical
Publication of KR101249711B1 publication Critical patent/KR101249711B1/ko
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
KR1020077028240A 2005-05-03 2006-05-02 1-클로로-4-(β-Ｄ-글루코피라노스-1-일)-2-［4-((Ｓ)-테트라하이드로푸란-3-일옥시)-벤질］-벤젠의 결정형, 이의 제조방법 및 약제 제조를 위한 이의 용도 Expired - Lifetime KR101249711B1 (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP05009669.2 2005-05-03
EP05009669 2005-05-03
EP05018012.4 2005-08-19
EP05018012 2005-08-19
PCT/EP2006/061956 WO2006117359A1 (en) 2005-05-03 2006-05-02 CRYSTALLINE FORM OF 1-CHLORO-4-(ß-D-GLUCOPYRANOS-1-YL)-2-[4-((S)-TETRAHYDROFURAN-3-YLOXY)-BENZYL]-BENZENE, A METHOD FOR ITS PREPARATION AND THE USE THEREOF FOR PREPARING MEDICAMENTS

Publications (2)

Publication Number Publication Date
KR20080015424A KR20080015424A (ko) 2008-02-19
KR101249711B1 true KR101249711B1 (ko) 2013-04-05

Family

ID=36593171

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020077028240A Expired - Lifetime KR101249711B1 (ko) 2005-05-03 2006-05-02 1-클로로-4-(β-Ｄ-글루코피라노스-1-일)-2-［4-((Ｓ)-테트라하이드로푸란-3-일옥시)-벤질］-벤젠의 결정형, 이의 제조방법 및 약제 제조를 위한 이의 용도

Country Status (32)

Country Link
US (2) US7713938B2 (https=)
EP (2) EP1888552B1 (https=)
JP (2) JP4226070B2 (https=)
KR (1) KR101249711B1 (https=)
CN (1) CN101155794B (https=)
AR (2) AR053720A1 (https=)
AT (1) ATE452883T1 (https=)
AU (1) AU2006243859B8 (https=)
BR (1) BRPI0610994B8 (https=)
CA (1) CA2606650C (https=)
CY (1) CY1109870T1 (https=)
DE (1) DE602006011310D1 (https=)
DK (1) DK1888552T3 (https=)
EA (1) EA013079B1 (https=)
ES (1) ES2337498T3 (https=)
HR (1) HRP20100033T1 (https=)
IL (1) IL187087A (https=)
ME (1) ME01173B (https=)
MX (1) MX2007013144A (https=)
MY (1) MY142108A (https=)
NO (1) NO339073B1 (https=)
NZ (1) NZ563563A (https=)
PE (2) PE20091063A1 (https=)
PL (1) PL1888552T3 (https=)
PT (1) PT1888552E (https=)
RS (1) RS51216B (https=)
SI (1) SI1888552T1 (https=)
TW (1) TWI344465B (https=)
UA (1) UA91546C2 (https=)
UY (1) UY29505A1 (https=)
WO (1) WO2006117359A1 (https=)
ZA (1) ZA200705883B (https=)

Families Citing this family (166)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7407955B2 (en) 2002-08-21 2008-08-05 Boehringer Ingelheim Pharma Gmbh & Co., Kg 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
EP1687308B1 (en) * 2003-11-17 2019-06-12 Merck & Cie Process for preparating (6R)-L-erythrotetrahydrobiopterin hydrochloride crystalline form B from other crystalline forms
CN103030617A (zh) * 2004-03-16 2013-04-10 贝林格尔.英格海姆国际有限公司 吡喃葡萄糖基取代的苯基衍生物、含该化合物的药物、其用途及其制造方法
WO2005118586A1 (en) * 2004-06-02 2005-12-15 Sandoz Ag Meropenem intermediate in crystalline form
DE102004054054A1 (de) 2004-11-05 2006-05-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
DE602005009745D1 (de) * 2004-12-16 2008-10-23 Boehringer Ingelheim Pharma Glucopyranosyl-substituierte benzen-derivate, medikamente mit solchen verbindungen, ihre verwendung und herstellungsverfahren dafür
JP5264183B2 (ja) * 2005-02-23 2013-08-14 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング グルコピラノシル置換（（ヘテロ）アリールエチニル−ベンジル）−ベンゼン誘導体及びナトリウム依存性グルコース共輸送体２（ｓｇｌｔ２）インヒビターとしてのそれらの使用
ATE453656T1 (de) * 2005-04-15 2010-01-15 Boehringer Ingelheim Int Glucopyranosyl-substituierte (heteroaryloxy- benzyl)-benzen-derivate als sglt-inhibitoren
UA91546C2 (uk) * 2005-05-03 2010-08-10 Бьорінгер Інгельхайм Інтернаціональ Гмбх КРИСТАЛІЧНА ФОРМА 1-ХЛОР-4-(β-D-ГЛЮКОПІРАНОЗ-1-ИЛ)-2-[4-((S)-ТЕТРАГІДРОФУРАН-3-ІЛОКСИ)-БЕНЗИЛ]-БЕНЗОЛУ, СПОСІБ ЇЇ ОДЕРЖАННЯ ТА ЇЇ ЗАСТОСУВАННЯ ПРИ ПРИГОТУВАННІ ЛІКАРСЬКИХ ЗАСОБІВ
US7723309B2 (en) * 2005-05-03 2010-05-25 Boehringer Ingelheim International Gmbh Crystalline forms of 1-chloro-4-(β-D-glucopyranos-1-yl)-2-[4-((R)-tetrahydrofuran-3-yloxy)-benzyl]-benzene, a method for its preparation and the use thereof for preparing medicaments
US7772191B2 (en) 2005-05-10 2010-08-10 Boehringer Ingelheim International Gmbh Processes for preparing of glucopyranosyl-substituted benzyl-benzene derivatives and intermediates therein
WO2007004230A2 (en) * 2005-07-05 2007-01-11 Hetero Drugs Limited A novel process for the preparation of didanosine using novel intermediates
AR054871A1 (es) * 2005-07-27 2007-07-25 Boehringer Ingelheim Int Derivados de (hetero)cicloalquiletinil-bencil)-benceno sustituidos con glucopiranosilo, medicamentos que contienen dichos compuestos, sus uso y proceso para su fabricacion
WO2007025943A2 (en) * 2005-08-30 2007-03-08 Boehringer Ingelheim International Gmbh Glucopyranosyl-substituted benzyl-benzene derivatives, medicaments containing such compounds, their use and process for their manufacture
AU2006289093A1 (en) * 2005-09-08 2007-03-15 Boehringer Ingelheim International Gmbh Crystalline forms of 1-chloro-4-(beta-D-glucopyranos-1-yl)-2-(4-ethynyl-benzyl)-benzene, methods for its preparation and the use thereof for preparing medicaments
AR056195A1 (es) * 2005-09-15 2007-09-26 Boehringer Ingelheim Int Procedimientos para preparar derivados de (etinil-bencil)-benceno sustituidos de glucopiranosilo y compuestos intermedios de los mismos
BRPI0616040A2 (pt) * 2005-09-21 2011-06-07 Nycomed Gmbh cloridrato de sulfonilpirról como inibidor de histona desacetilases
EP2404911A1 (en) * 2005-10-31 2012-01-11 Janssen Pharmaceutica NV Novel processes for the preparation of piperazinyl and diazapanyl benzamide derivatives
AR059489A1 (es) * 2006-02-15 2008-04-09 Boehringer Ingelheim Vetmed Derivados de benzonitrilo sustituidos con glucopiranosilo, composiciones farmaceuticas que contienen compuestos de este tipo, su uso y procedimiento para su fabricacion
PE20080697A1 (es) * 2006-05-03 2008-08-05 Boehringer Ingelheim Int Derivados de benzonitrilo sustituidos con glucopiranosilo, composiciones farmaceuticas que contienen compuestos de este tipo, su uso y procedimiento para su fabricacion
EP2540725A1 (de) 2006-05-04 2013-01-02 Boehringer Ingelheim International GmbH Polymorphe von 1-((4-Methyl-chinazolin-2-yl)methyl)-3-methyl-7-(2-butin-1-yl)-8-(3-(R)-amino-piperidin-1-yl)xanthin
EP1852108A1 (en) 2006-05-04 2007-11-07 Boehringer Ingelheim Pharma GmbH & Co.KG DPP IV inhibitor formulations
PE20080251A1 (es) 2006-05-04 2008-04-25 Boehringer Ingelheim Int Usos de inhibidores de dpp iv
CA2656057C (en) * 2006-06-16 2012-10-02 H. Lundbeck A/S Crystalline forms of 4-[2-(4-methylphenylsulfanyl)-phenyl]piperidine with combined serotonin and norepinephrine reuptake inhibition for the treatment of neuropathic pain
WO2008020011A1 (en) * 2006-08-15 2008-02-21 Boehringer Ingelheim International Gmbh Glucopyranosyl-substituted cyclopropylbenzene derivatives, pharmaceutical compositions containing such compounds, their use as sglt inhibitors and process for their manufacture
WO2008034859A1 (en) * 2006-09-21 2008-03-27 Boehringer Ingelheim International Gmbh Glucopyranosyl-substituted difluorobenzyl-benzene derivatives, medicaments containing such compounds, their use and process for their manufacture
WO2008049923A1 (en) * 2006-10-27 2008-05-02 Boehringer Ingelheim International Gmbh CRYSTALLINE FORM OF 4-(ß-D-GLUCOPYRANOS-1-YL)-1-METHYL-2-[4-((S)-TETRAHYDROFURAN-3-YLOXY)-BENZYL]-BENZENE, A METHOD FOR ITS PREPARATION AND THE USE THEREOF FOR PREPARING MEDICAMENTS
CA2667345C (en) * 2006-10-27 2016-03-22 Signal Pharmaceuticals, Llc Solid forms comprising 4-[9-(tetrahydro-furan-3-yl)-8-(2,4,6-trifluoro-phenylamino)-9h-purin-2-ylamino]-cyclohexan-1-ol, compositions thereof, and uses therewith
CA2668623A1 (en) * 2006-11-06 2008-05-15 Boehringer Ingelheim International Gmbh Glucopyranosyl-substituted benzyl-benzonitrile derivatives, medicaments containing such compounds, their use and process for their manufacture
WO2008075736A1 (ja) 2006-12-21 2008-06-26 Astellas Pharma Inc. Ｃ－グリコシド誘導体の製造方法及びその合成中間体
WO2008101939A1 (en) * 2007-02-21 2008-08-28 Boehringer Ingelheim International Gmbh Tetrasubstituted glucopyranosylated benzene derivatives, medicaments containing such compounds, their use and process for their manufacture
CL2008002427A1 (es) 2007-08-16 2009-09-11 Boehringer Ingelheim Int Composicion farmaceutica que comprende 1-cloro-4-(b-d-glucopiranos-1-il)-2-[4-((s)-tetrahidrofurano-3-iloxi)bencil]-benceno combinado con 1-[(4-metilquinazolin-2-il)metil]-3-metil-7-(2-butin-1-il)-8-(3-(r)-aminopiperidin-1-il)xantina; y su uso para tratar diabetes mellitus tipo 2.
NZ583369A (en) 2007-08-23 2011-08-26 Theracos Inc Benzylbenzene derivatives and methods of use
JP5498392B2 (ja) * 2007-11-30 2014-05-21 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング １，５−ジヒドロ−ピラゾロ［３，４−ｄ］ピリミジン−４−オン誘導体及びｃｎｓ障害の治療のためのｐｄｅ９ａモジュレーターとしてのそれらの使用
UA101004C2 (en) 2007-12-13 2013-02-25 Теракос, Инк. Derivatives of benzylphenylcyclohexane and use thereof
CL2008003653A1 (es) 2008-01-17 2010-03-05 Mitsubishi Tanabe Pharma Corp Uso de un inhibidor de sglt derivado de glucopiranosilo y un inhibidor de dppiv seleccionado para tratar la diabetes; y composicion farmaceutica.
EP2085397A1 (en) * 2008-01-21 2009-08-05 Esteve Quimica, S.A. Crystalline form of abacavir
ES2541141T3 (es) * 2008-01-31 2015-07-16 Astellas Pharma Inc. Composición farmacéutica para el tratamiento de las enfermedades del hígado graso
US7935817B2 (en) * 2008-03-31 2011-05-03 Apotex Pharmachem Inc. Salt form and cocrystals of adefovir dipivoxil and processes for preparation thereof
UA105362C2 (en) 2008-04-02 2014-05-12 Бьорингер Ингельхайм Интернациональ Гмбх 1-heterocyclyl-1, 5-dihydro-pyrazolo [3, 4-d] pyrimidin-4-one derivatives and their use as pde9a modulators
PE20091730A1 (es) 2008-04-03 2009-12-10 Boehringer Ingelheim Int Formulaciones que comprenden un inhibidor de dpp4
AR071318A1 (es) * 2008-04-15 2010-06-09 Basilea Pharmaceutica Ag Benzhidril ester del acido (6r,7r)-7-{2-(5-amino-[1,2,4]tiadiazol-3-il)-2-[(z)-tritiloxiimino]-acetilamino}-3-[(r)-1'-terc-butoxicarbonil-2-oxo-[1,3']bipirrolidinil-(3e)-ilidenometil]-8-oxo-5-tia-1-aza-biciclo[4.2.0]oct-2-eno-2-carboxilico cristalino; su elaboracion y uso
US8097719B2 (en) * 2008-07-15 2012-01-17 Genesen Labs Meropenem intermediate in novel crystalline form and a method of manufacture of meropenem
AU2009270936B2 (en) 2008-07-15 2014-12-18 Theracos, Inc. Deuterated benzylbenzene derivatives and methods of use
BRPI0916997A2 (pt) 2008-08-06 2020-12-15 Boehringer Ingelheim International Gmbh Inibidor de dpp-4 e seu uso
CN103910702A (zh) * 2008-08-22 2014-07-09 泰拉科斯有限公司 制备sglt2抑制剂的方法
AU2009286380B2 (en) 2008-08-28 2011-09-15 Pfizer Inc. Dioxa-bicyclo[3.2.1.]octane-2,3,4-triol derivatives
KR20110063447A (ko) 2008-09-08 2011-06-10 베링거 인겔하임 인터내셔날 게엠베하 피라졸로피리미딘 및 ｃｎｓ 장애의 치료를 위한 이들의 용도
US20200155558A1 (en) 2018-11-20 2020-05-21 Boehringer Ingelheim International Gmbh Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
AU2016213789B2 (en) * 2009-02-13 2018-01-18 Boehringer Ingelheim International Gmbh SGLT-2 inhibitor for treating type 1 diabetes mellitus, type 2 diabetes mellitus, impaired glucose tolerance or hyperglycemia
AU2014200258B2 (en) * 2009-02-13 2016-05-12 Boehringer Ingelheim International Gmbh SGLT-2 inhibitor for treating type 1 diabetes mellitus, type 2 diabetes mellitus, impaired glucose tolerance or hyperglycemia
JP5685550B2 (ja) 2009-02-13 2015-03-18 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Ｓｇｌｔ２阻害剤、ｄｐｐ−ｉｖ阻害剤、更に必要により抗糖尿病薬を含む医薬組成物及びその使用
US20110014284A1 (en) * 2009-02-13 2011-01-20 Boehringer Ingelheim International Gmbh Pharmaceutical composition, pharmaceutical dosage form, process for their preparation, methods for treating and uses thereof
DK2396005T3 (da) * 2009-02-13 2026-02-09 Boehringer Ingelheim Int Sglt2 hæmmer til at forbedre glykæmisk kontrol
UY32427A (es) * 2009-02-13 2010-09-30 Boheringer Ingelheim Internat Gmbh Composicion farmaceutica, forma farmaceutica, procedimiento para su preparacion, metodos de tratamiento y usos de la misma
PT2414363E (pt) 2009-03-31 2014-02-26 Boehringer Ingelheim Int Derivados de 1-heterociclil-1,5-di-hidro-pirazolo[3,4- d]pirimidin-4-ona e sua utilização como moduladores de pde9a
TW201118099A (en) * 2009-08-12 2011-06-01 Boehringer Ingelheim Int New compounds for the treatment of CNS disorders
EA020798B1 (ru) * 2009-09-30 2015-01-30 Бёрингер Ингельхайм Интернациональ Гмбх СПОСОБ ПОЛУЧЕНИЯ КРИСТАЛЛИЧЕСКОЙ ФОРМЫ 1-ХЛОР-4-(β-D-ГЛЮКОПИРАНОЗ-1-ИЛ)-2-[4-((S)-ТЕТРАГИДРОФУРАН-3-ИЛОКСИ)БЕНЗИЛ]БЕНЗОЛА
PT2486029E (pt) 2009-09-30 2015-10-14 Boehringer Ingelheim Int Processos para a preparação de derivados de benzil-benzeno substituídos com glucopiranosilo
UY32919A (es) * 2009-10-02 2011-04-29 Boehringer Ingelheim Int Composición farmacéutica, forma de dosificación farmacéutica, procedimiento para su preparación, mé todos para su tratamiento y sus usos
US8163704B2 (en) 2009-10-20 2012-04-24 Novartis Ag Glycoside derivatives and uses thereof
RS53827B1 (sr) 2009-11-02 2015-06-30 Pfizer Inc. Derivati dioksa-biciklo[3.2.1]oktan-2,3,4-triola
KR20240090632A (ko) 2009-11-27 2024-06-21 베링거 인겔하임 인터내셔날 게엠베하 리나글립틴과 같은 ｄｐｐ－ｉｖ 억제제를 사용한 유전자형 검사된 당뇨병 환자의 치료
KR101713453B1 (ko) 2010-03-12 2017-03-07 오메로스 코포레이션 Pde10 억제제 및 관련 조성물 및 방법
EP2552442A1 (en) * 2010-03-30 2013-02-06 Boehringer Ingelheim International GmbH Pharmaceutical composition comprising an sglt2 inhibitor and a ppar- gamma agonist and uses thereof
CN102946875A (zh) 2010-05-05 2013-02-27 贝林格尔.英格海姆国际有限公司 组合疗法
WO2011153712A1 (en) 2010-06-12 2011-12-15 Theracos, Inc. Crystalline form of benzylbenzene sglt2 inhibitor
EP2603511B1 (en) 2010-08-12 2017-03-15 Boehringer Ingelheim International GmbH 6-cycloalkyl-1, 5-dihydro-pyrazolo [3, 4-d] pyrimidin-4-one derivatives and their use as pde9a inhibitors
JP2013536859A (ja) * 2010-09-01 2013-09-26 アリーナ ファーマシューティカルズ， インコーポレイテッド ５−ｈｔ２ｃアゴニストの非吸湿性塩
WO2012041898A1 (en) 2010-09-29 2012-04-05 Celon Pharma Sp. Z O.O. Combination of sglt2 inhibitor and a sugar compound for the treatment of diabetes
WO2012059416A1 (en) 2010-11-02 2012-05-10 Boehringer Ingelheim International Gmbh Pharmaceutical combinations for the treatment of metabolic disorders
US20120283169A1 (en) 2010-11-08 2012-11-08 Boehringer Ingelheim International Gmbh Pharmaceutical composition, methods for treating and uses thereof
AR083878A1 (es) 2010-11-15 2013-03-27 Boehringer Ingelheim Int Terapia antidiabetica vasoprotectora y cardioprotectora, linagliptina, metodo de tratamiento
US20130035281A1 (en) 2011-02-09 2013-02-07 Boehringer Ingelheim International Gmbh Pharmaceutical composition, methods for treating and uses thereof
US8809345B2 (en) 2011-02-15 2014-08-19 Boehringer Ingelheim International Gmbh 6-cycloalkyl-pyrazolopyrimidinones for the treatment of CNS disorders
AR085689A1 (es) 2011-03-07 2013-10-23 Boehringer Ingelheim Int Composiciones farmaceuticas de metformina, linagliptina y un inhibidor de sglt-2
BR112013031032A2 (pt) 2011-06-03 2016-11-29 Boehringer Ingelheim Int inibidores de sglt-2 para o tratamento de distúrbios metabólicos em pacientes tratados com agentes neurolépticos
US20130035298A1 (en) * 2011-07-08 2013-02-07 Boehringer Ingelheim International Gmbh Pharmaceutical composition, methods for treating and uses thereof
EP2760859A1 (en) * 2011-09-30 2014-08-06 Sunshine Lake Pharma Co., Ltd Crystalline forms of azilsartan and preparation and uses thereof
US9555001B2 (en) 2012-03-07 2017-01-31 Boehringer Ingelheim International Gmbh Pharmaceutical composition and uses thereof
US9192617B2 (en) 2012-03-20 2015-11-24 Boehringer Ingelheim International Gmbh Pharmaceutical composition, methods for treating and uses thereof
WO2013152476A1 (en) 2012-04-10 2013-10-17 Theracos, Inc. Process for the preparation of benzylbenzene sglt2 inhibitors
US20130303446A1 (en) 2012-05-09 2013-11-14 Boehringer Ingelheim International Gmbh Pharmaceutical combinations for the treatment of metabolic disorders
JP6218811B2 (ja) 2012-05-14 2017-10-25 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Ｓｉｒｓ及び／又は敗血症の治療に用いるｄｐｐ−４阻害薬としてのキサンチン誘導体
JP6224084B2 (ja) 2012-05-14 2017-11-01 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 糸球体上皮細胞関連障害及び／又はネフローゼ症候群の治療に用いるｄｐｐ−４阻害薬としてのキサンチン誘導体
PT2981269T (pt) 2013-04-04 2023-10-10 Boehringer Ingelheim Vetmedica Gmbh Tratamento de distúrbios metabólicos em animais equinos
US11813275B2 (en) * 2013-04-05 2023-11-14 Boehringer Ingelheim International Gmbh Pharmaceutical composition, methods for treating and uses thereof
CA2812016A1 (en) * 2013-04-05 2014-10-05 Boehringer Ingelheim International Gmbh Pharmaceutical composition, methods for treating and uses thereof
CA2812519A1 (en) 2013-04-05 2014-10-05 Boehringer Ingelheim International Gmbh Pharmaceutical composition, methods for treating and uses thereof
TR201901110T4 (tr) 2013-04-05 2019-02-21 Boehringer Ingelheim Int Empagliflozinin terapötik kullanımları.
HK1213818A1 (zh) * 2013-04-05 2016-07-15 勃林格殷格翰国际有限公司 依帕列净的治疗用途
US20160000816A1 (en) * 2013-04-05 2016-01-07 Boehringer Ingelheim International Gmbh Pharmaceutical composition, methods for treating and uses thereof
EP4678242A3 (en) * 2013-04-18 2026-03-18 Boehringer Ingelheim International GmbH Pharmaceutical composition, methods for treating and uses thereof
CN105611920B (zh) 2013-10-12 2021-07-16 泰拉科斯萨普有限责任公司 羟基-二苯甲烷衍生物的制备
ES2969764T3 (es) 2013-12-17 2024-05-22 Boehringer Ingelheim Vetmedica Gmbh Un inhibidor de SGLT-2 para usar en el tratamiento de un trastorno metabólico en animales felinos
US9902751B2 (en) 2013-12-30 2018-02-27 Mylan Laboratories Limited Process for the preparation of empagliflozin
CN115671290A (zh) * 2014-01-23 2023-02-03 勃林格殷格翰动物保健有限公司 犬科动物中代谢紊乱的治疗
WO2015150299A2 (en) 2014-04-01 2015-10-08 Boehringer Ingelheim Vetmedica Gmbh Treatment of metabolic disorders in equine animals
NZ630803A (en) 2014-04-28 2016-03-31 Omeros Corp Optically active pde10 inhibitor
NZ716494A (en) 2014-04-28 2017-07-28 Omeros Corp Processes and intermediates for the preparation of a pde10 inhibitor
CN105384730A (zh) * 2014-09-03 2016-03-09 杭州普晒医药科技有限公司 依帕列净的晶型及其制备方法、药物组合物和用途
CN105481843A (zh) * 2014-09-19 2016-04-13 重庆医药工业研究院有限责任公司 一种恩格列净无定型物及其制备方法
WO2016046150A1 (en) 2014-09-25 2016-03-31 Boehringer Ingelheim Vetmedica Gmbh Combination treatment of sglt2 inhibitors and dopamine agonists for preventing metabolic disorders in equine animals
WO2016051368A1 (en) 2014-10-01 2016-04-07 Mylan Laboratories Ltd Complex of amorphous empagliflozin and a cyclodextrin
CZ2015110A3 (cs) 2015-02-18 2016-08-31 Zentiva, K.S. Pevné formy empagliflozinu
EA201791982A1 (ru) 2015-03-09 2020-02-17 Интекрин Терапьютикс, Инк. Способы лечения неалкогольной жировой болезни печени и/или липодистрофии
CZ2015279A3 (cs) 2015-04-24 2016-11-02 Zentiva, K.S. Pevné formy amorfního empagliflozinu
KR20170139074A (ko) 2015-04-24 2017-12-18 오메로스 코포레이션 Pde10 억제제 및 관련 조성물 및 방법
CN104788438B (zh) * 2015-05-04 2018-02-02 南京华威医药科技集团有限公司 恩格列净b晶型及其制备
CN106317035A (zh) * 2015-06-23 2017-01-11 中美华世通生物医药科技（武汉）有限公司 恩格列净单晶及其制备方法和用途
KR102659761B1 (ko) 2015-08-27 2024-04-24 베링거잉겔하임베트메디카게엠베하 Sglt-2 억제제를 포함하는 액상 약제학적 조성물
EP3362055B1 (en) 2015-10-15 2023-01-18 Boehringer Ingelheim International GmbH Sglt-2 inhibitor for use in the treatment of a metabolic myopathy
WO2017079678A1 (en) 2015-11-04 2017-05-11 Omeros Corporation Solid state forms of a pde10 inhibitor
WO2017141202A1 (en) * 2016-02-17 2017-08-24 Lupin Limited Complex of sglt2 inhibitor and process for preparation thereof
BR112018016001A2 (en) * 2016-03-16 2018-12-18 Boehringer Ingelheim International Gmbh pharmaceutical composition, treatment methods and uses thereof
WO2017203457A1 (en) * 2016-05-26 2017-11-30 Dr. Reddy's Laboratories Limited Solid state forms of empagliflozin
CN109310697A (zh) 2016-06-10 2019-02-05 勃林格殷格翰国际有限公司 利格列汀和二甲双胍的组合
JP2019530722A (ja) 2016-10-13 2019-10-24 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング グルコピラノシル置換ベンジル−ベンゼン誘導体を調製するための方法
US20210212968A1 (en) 2016-10-19 2021-07-15 Boehringer Ingelheim International Gmbh Combinations comprising an ssao/vap-1 inhibitor and a sglt2 inhibitor, uses thereof
KR20190084096A (ko) 2016-11-10 2019-07-15 베링거 인겔하임 인터내셔날 게엠베하 약제학적 조성물, 치료 방법 및 이의 용도
US20200017483A1 (en) * 2017-03-10 2020-01-16 Msn Laboratories Private Limited, R&D Center A process for the preparation of d-glucitol, 1,5-anhydro-1-c-[4-chloro-3-[[4- [[(3s)-tetrahydro-3-furanyl]oxy]phenyl]methyl]phenyl]-, ( 1 s)
JP2020515639A (ja) 2017-04-03 2020-05-28 コヒラス・バイオサイエンシズ・インコーポレイテッド 進行性核上性麻痺の処置のためのＰＰＡＲγアゴニスト
CN111989103A (zh) 2018-04-17 2020-11-24 勃林格殷格翰国际有限公司 药物组合物、其治疗方法和用途
CZ2018188A3 (cs) 2018-04-18 2019-10-30 Zentiva, K.S. Částice s obsahem amorfního empagliflozinu, způsob jejich přípravy a farmaceutický přípravek
KR102204439B1 (ko) 2018-05-14 2021-01-18 에이치케이이노엔 주식회사 Sglt-2 억제제 및 dpp-iv 억제제를 포함하는 약제학적 조성물
JP2021532191A (ja) 2018-07-25 2021-11-25 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング アルポート症候群の治療に使用するためのエンパグリフロジン
WO2020039394A1 (en) 2018-08-24 2020-02-27 Novartis Ag New drug combinations
WO2020058095A1 (en) 2018-09-19 2020-03-26 Galenicum Health S.L.U. Pharmaceutical compositions of empagliflozin
US20210393621A1 (en) 2018-10-26 2021-12-23 The Research Foundation For The State University Of New York Combination serotonin specific reuptake inhibitor and serotonin 1a receptor partial agonist for reducing l-dopa-induced dyskinesia
US12213970B2 (en) 2018-10-29 2025-02-04 Boehringer Ingelheim International Gmbh Pyridinyl sulfonamide derivatives, pharmaceutical compositions and uses thereof
KR102812426B1 (ko) 2018-10-29 2025-05-26 베링거 인겔하임 인터내셔날 게엠베하 피리디닐 설폰아미드 유도체, 약제학적 조성물 및 이의 용도
EP4064854A1 (en) 2019-11-28 2022-10-05 Boehringer Ingelheim Vetmedica GmbH Use of sglt-2 inhibitors in the drying-off of non-human mammals
WO2021123165A1 (en) 2019-12-19 2021-06-24 Krka, D.D., Novo Mesto Dosage form comprising amorphous solid solution of empagliflozin with polymer
KR102111248B1 (ko) 2019-12-30 2020-05-14 유니셀랩 주식회사 새로운 엠파글리플로진의 공결정
AU2021222297B2 (en) 2020-02-17 2026-01-22 Boehringer Ingelheim Vetmedica Gmbh Use of SGLT-2 inhibitors for the prevention and/or treatment of cardiac diseases in felines
IL296035A (en) 2020-03-06 2022-10-01 Vertex Pharma Methods of treating apol-1 dependent focal segmental glomerulosclerosis
CN111303230B (zh) * 2020-03-09 2021-07-13 中国食品药品检定研究院 一种黄体酮共晶物及其制备方法和用途
KR102207319B1 (ko) 2020-03-23 2021-01-25 유니셀랩 주식회사 새로운 엠파글리플로진의 공결정
KR102150825B1 (ko) 2020-04-06 2020-09-03 유니셀랩 주식회사 새로운 sglt-2 억제제의 신규한 공결정
US20230110193A1 (en) 2020-04-07 2023-04-13 Boehringer Ingelheim International Gmbh Methods for the treatment of headache disorders
CA3180674A1 (en) 2020-04-22 2021-10-28 Bayer Aktiengesellschaft Combination of finerenone and a sglt2 inhibitor for the treatment and/or prevention of cardiovascular and/or renal diseases
WO2021250565A1 (en) * 2020-06-10 2021-12-16 Hikal Limited An improved process for preparation of empagliflozin and its crystalline polymorph
WO2022051316A1 (en) 2020-09-03 2022-03-10 Coherus Biosciences, Inc. Fixed dose combinations of chs-131 and a sglt-2 inhibitor
KR102218323B1 (ko) 2020-09-09 2021-02-22 유니셀랩 주식회사 효율적이고 상전이가 되지 않는 엠파글리플로진 무정형의 제조방법
KR20220080880A (ko) 2020-12-08 2022-06-15 주식회사 종근당 엠파글리플로진 공결정을 함유하는 약제학적 조성물
US20240269105A1 (en) 2021-07-28 2024-08-15 Boehringer Ingelheim Vetmedica Gmbh Use of sglt-2 inhibitors for the prevention and/or treatment of hypertension in non-human mammals
JP2024525981A (ja) 2021-07-28 2024-07-12 ベーリンガー インゲルハイム フェトメディカ ゲーエムベーハー ヒト以外の哺乳動物における腎疾患の予防及び／又は治療のためのｓｇｌｔ－２阻害剤の使用
JP2024527434A (ja) 2021-07-28 2024-07-24 ベーリンガー インゲルハイム フェトメディカ ゲーエムベーハー ネコ科動物を除く非ヒト哺乳動物、特にイヌ科動物における心臓疾患の予防及び／又は治療のためのｓｇｌｔ－２阻害剤の使用
US20250170128A1 (en) 2021-12-30 2025-05-29 NEWAMSTERDAM PHARMA B.V. (Dutch Chamber of Commerce No. 5597 1946) Obicetrapib and SGLT2 Inhibitor Combination
AU2023277704A1 (en) 2022-05-25 2024-12-05 Boehringer Ingelheim Vetmedica Gmbh Aqueous pharmaceutical compositions comprising sglt-2 inhibitors
EP4299055A1 (en) 2022-06-29 2024-01-03 Sanovel Ilac Sanayi Ve Ticaret A.S. Oral dosage formulations comprising empagliflozin
EP4342459A1 (en) 2022-09-20 2024-03-27 Galenicum Health S.L.U. Pharmaceutical compositions of empagliflozin
EP4378455A1 (en) 2022-11-29 2024-06-05 Sanovel Ilac Sanayi Ve Ticaret A.S. A pharmaceutical formulation comprising empagliflozin
EP4420658A1 (en) 2023-02-24 2024-08-28 Sanovel Ilac Sanayi Ve Ticaret A.S. A film coated tablet comprising empagliflozin
EP4676494A1 (en) 2023-03-06 2026-01-14 Boehringer Ingelheim Vetmedica GmbH Systems for delivery of liquid pharmaceutical compositions in particular comprising one or more sglt-2 inhibitor(s)
EP4442254A1 (en) 2023-04-04 2024-10-09 Sanovel Ilac Sanayi Ve Ticaret A.S. Film coated tablets comprising empagliflozin
EP4442253A1 (en) 2023-04-04 2024-10-09 Sanovel Ilac Sanayi Ve Ticaret A.S. A film coated tablet comprising empagliflozin and surfactant
EP4442252A1 (en) 2023-04-04 2024-10-09 Sanovel Ilac Sanayi Ve Ticaret A.S. A tablet formulation of a solid dispersion comprising empagliflozin
TW202446389A (zh) 2023-04-24 2024-12-01 荷蘭商新阿姆斯特丹製藥公司 非晶形奧比特拉(obicetrapib)與sglt2抑制劑之組合
KR20260019532A (ko) 2023-05-24 2026-02-10 베링거잉겔하임베트메디카게엠베하 하나 이상의 sglt-2 억제제와 텔미사르탄을 포함하는 비인간 포유류의 신장 질환 및/또는 고혈압의 병용 치료 및/또는 예방
US20240390317A1 (en) 2023-05-24 2024-11-28 Boehringer Ingelheim Vetmedica Gmbh Combination treatment and/or prevention of cardiac diseases in non-human mammals comprising one or more sglt-2 inhibitors and pimobendan and/or telmisartan
KR20250007816A (ko) 2023-07-06 2025-01-14 주식회사 경보제약 엠파글리플로진 ２ｌ­프롤린의 신규 결정형 및 이의 제조방법
KR20250038170A (ko) 2023-09-11 2025-03-19 동광제약 주식회사 엠파글리플로진의 무정형 안정화 방법
TW202543596A (zh) 2024-03-15 2025-11-16 法商因文帝華公司 預防接受過氧化物酶體增生劑活化受體（ppar）促效劑治療患者之血液病症
WO2025224069A1 (en) 2024-04-23 2025-10-30 Bayer Aktiengesellschaft Co-crystals of finerenone, pecavaptan, and sglt2 inhibitors
CN119735586A (zh) * 2025-02-25 2025-04-01 济南大学 一种恩格列净晶型iii及其制备方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1385856A2 (en) * 2001-04-11 2004-02-04 Bristol-Myers Squibb Company Amino acid complexes of c-aryl glucosides for treatment of diabetes and method

Family Cites Families (79)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3174901A (en) * 1963-01-31 1965-03-23 Jan Marcel Didier Aron Samuel Process for the oral treatment of diabetes
NL167151C (nl) * 1971-04-09 1981-11-16 Acf Chemiefarma Nv Werkwijze ter bereiding van geneesmiddelen met anti-parasitaire werking op basis van halogeen bevatten- de 2,2'-methyleendifenolderivaten, alsmede werkwijze ter bereiding van deze geneeskrachtige verbindingen.
NO154918C (no) * 1977-08-27 1987-01-14 Bayer Ag Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin.
DE2951135A1 (de) * 1979-12-19 1981-06-25 Hoechst Ag, 6230 Frankfurt Sulfonylharnstoffe, verfahren zu ihrer herstellung, pharmazeutische praeparate auf basis dieser verbindungen und ihre verwendung
JPS58164502A (ja) 1982-03-26 1983-09-29 Chugai Pharmaceut Co Ltd 除草用組成物
US4786755A (en) 1985-06-03 1988-11-22 Warner-Lambert Company Diphenic acid monoamides
US4602023A (en) 1985-06-03 1986-07-22 Warner-Lambert Company Diphenic acid monoamides
US4786023A (en) * 1987-08-19 1988-11-22 Harris Leverett D Drafting implement holder
AU6024998A (en) 1997-01-15 1998-08-07 Glycomed Incorporated Aryl c-glycoside compounds and sulfated esters thereof
JPH11124392A (ja) 1997-10-21 1999-05-11 Sankyo Co Ltd Ｃ−グリコシル化されたアリールスズ化合物
US6613806B1 (en) * 1999-01-29 2003-09-02 Basf Corporation Enhancement of the efficacy of benzoylbenzenes
KR100591585B1 (ko) * 1999-08-31 2006-06-20 깃세이 야쿠힌 고교 가부시키가이샤 글루코피라노실옥시피라졸 유도체, 그것을 함유하는 의약조성물 및 그 제조 중간체
PH12000002657B1 (en) 1999-10-12 2006-02-21 Bristol Myers Squibb Co C-aryl glucoside SGLT2 inhibitors
US6515117B2 (en) 1999-10-12 2003-02-04 Bristol-Myers Squibb Company C-aryl glucoside SGLT2 inhibitors and method
JP4456768B2 (ja) 2000-02-02 2010-04-28 壽製薬株式会社 Ｃ−配糖体を含有する薬剤
US6627611B2 (en) 2000-02-02 2003-09-30 Kotobuki Pharmaceutical Co Ltd C-glycosides and preparation of thereof as antidiabetic agents
US6683056B2 (en) 2000-03-30 2004-01-27 Bristol-Myers Squibb Company O-aryl glucoside SGLT2 inhibitors and method
SK287811B6 (sk) 2000-09-29 2011-10-04 Kissei Pharmaceutical Co., Ltd Glukopyranozyloxybenzylbenzénový derivát, farmaceutická kompozícia a ľudský SGLT2-inhibítor tento derivát obsahujúci a použitie tohto derivátu
EP1344780A4 (en) 2000-11-30 2004-01-28 Kissei Pharmaceutical GLUCOPYRANOSYLOXYBENZYLBENZOLE DERIVATIVES, MEDICAL COMPOSITIONS CONTAINING THESE COMPOUNDS AND INTERMEDIATE PRODUCTS FOR THEIR PREPARATION
TWI255817B (en) 2001-02-14 2006-06-01 Kissei Pharmaceutical Glucopyranosyloxybenzylbenzene derivatives and medicinal use thereof
US6936590B2 (en) 2001-03-13 2005-08-30 Bristol Myers Squibb Company C-aryl glucoside SGLT2 inhibitors and method
JP3698067B2 (ja) * 2001-03-30 2005-09-21 Ｊｓｒ株式会社 電子吸引性基および電子供与性基を有するモノマー、それを用いた共重合体、ならびにプロトン伝導膜
WO2003020737A1 (en) * 2001-09-05 2003-03-13 Bristol-Myers Squibb Company O-pyrazole glucoside sglt2 inhibitors and method of use
TWI254635B (en) 2002-08-05 2006-05-11 Yamanouchi Pharma Co Ltd Azulene derivative and salt thereof
US6744112B2 (en) * 2002-10-01 2004-06-01 International Business Machines Corporation Multiple chip guard rings for integrated circuit and chip guard ring interconnect
DE10258008B4 (de) 2002-12-12 2006-02-02 Sanofi-Aventis Deutschland Gmbh Heterocyclische Fluorglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel
DE10258007B4 (de) 2002-12-12 2006-02-09 Sanofi-Aventis Deutschland Gmbh Aromatische Fluorglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel
JP2006516257A (ja) 2003-01-03 2006-06-29 ブリストル−マイヤーズ　スクイブ　カンパニー Ｃ−アリールグルコシドｓｇｌｔ２阻害剤の製造法
WO2004076470A2 (en) 2003-02-27 2004-09-10 Bristol-Myers Squibb Company A non-cryogenic process for forming glycosides
ES2363941T3 (es) 2003-03-14 2011-08-19 Astellas Pharma Inc. Derivados de c-glucósido para el tratamiento de diabetes.
CA2528152A1 (en) * 2003-06-03 2005-01-06 The Regents Of The University Of California Compositions and methods for treatment of disease with acetylated disaccharides
JP2004359630A (ja) 2003-06-06 2004-12-24 Yamanouchi Pharmaceut Co Ltd ジフルオロジフェニルメタン誘導体及びその塩
ES2531660T3 (es) 2003-08-01 2015-03-18 Mitsubishi Tanabe Pharma Corporation Compuestos novedosos que tienen actividad inhibidora frente a transportador de glucosa dependiente de sodio
EP1679965A4 (en) 2003-08-01 2009-05-27 Janssen Pharmaceutica Nv SUBSTITUTED ANELLIERED HETEROCYCLIC C-GLYCOSIDES
US7375090B2 (en) 2003-08-26 2008-05-20 Boehringer Ingelheim International Gmbh Glucopyranosyloxy-pyrazoles, pharmaceutical compositions containing these compounds, the use thereof and processed for the preparation thereof
EP1660509B1 (de) 2003-08-26 2009-02-04 Boehringer Ingelheim International GmbH Glucopyranosyloxy-pyrazole, diese verbindungen enthaltende arzneimittel, deren verwendung und verfahren zu ihrer herstellung
US20050085680A1 (en) * 2003-10-21 2005-04-21 Joseph Auerbach Method for industrial decontamination
US7371732B2 (en) 2003-12-22 2008-05-13 Boehringer Ingelheim International Gmbh Glucopyranosyloxy-substituted aromatic compounds, medicaments containing such compounds, their use and process for their manufacture
PL381247A1 (pl) 2004-03-04 2007-05-14 Kissei Pharmaceutical Co., Ltd. Skondensowana pochodna heterocykliczna, zawierająca ją kompozycja lecznicza, oraz jej zastosowanie lecznicze
BRPI0508259A (pt) 2004-03-04 2007-07-31 Kissei Pharmaceutical derivado heterocìclico fundido, composição medicinal contendo o mesmo, e uso medicinal do mesmo
CN103030617A (zh) 2004-03-16 2013-04-10 贝林格尔.英格海姆国际有限公司 吡喃葡萄糖基取代的苯基衍生物、含该化合物的药物、其用途及其制造方法
US7393836B2 (en) 2004-07-06 2008-07-01 Boehringer Ingelheim International Gmbh D-xylopyranosyl-substituted phenyl derivatives, medicaments containing such compounds, their use and process for their manufacture
DE102004034690A1 (de) 2004-07-17 2006-02-02 Boehringer Ingelheim Pharma Gmbh & Co. Kg Methyliden-D-xylopyranosyl-und Oxo-D-xylopyranosyl-substituierte Phenyle, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung
TW200606129A (en) 2004-07-26 2006-02-16 Chugai Pharmaceutical Co Ltd Novel cyclohexane derivative, its prodrug, its salt and diabetic therapeutic agent containing the same
WO2006010557A1 (de) 2004-07-27 2006-02-02 Boehringer Ingelheim International Gmbh D-glucopyranosyl-phenyl-substituierte cyclen, diese verbindungen enthaltende arzneimittel, deren verwendung und verfahren zu ihrer herstellung
WO2006018150A1 (de) 2004-08-11 2006-02-23 Boehringer Ingelheim International Gmbh D-xylopyranosyl-phenyl-substituierte cyclen, diese verbindungen enthaltende arzneimittel, deren verwendung und verfahren zu ihrer herstellung
AR051446A1 (es) 2004-09-23 2007-01-17 Bristol Myers Squibb Co Glucosidos de c-arilo como inhibidores selectivos de transportadores de glucosa (sglt2)
DE102004048388A1 (de) 2004-10-01 2006-04-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg D-Pyranosyl-substituierte Phenyle, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung
DE602005009745D1 (de) 2004-12-16 2008-10-23 Boehringer Ingelheim Pharma Glucopyranosyl-substituierte benzen-derivate, medikamente mit solchen verbindungen, ihre verwendung und herstellungsverfahren dafür
JP5264183B2 (ja) 2005-02-23 2013-08-14 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング グルコピラノシル置換（（ヘテロ）アリールエチニル−ベンジル）−ベンゼン誘導体及びナトリウム依存性グルコース共輸送体２（ｓｇｌｔ２）インヒビターとしてのそれらの使用
ATE453656T1 (de) 2005-04-15 2010-01-15 Boehringer Ingelheim Int Glucopyranosyl-substituierte (heteroaryloxy- benzyl)-benzen-derivate als sglt-inhibitoren
US7723309B2 (en) 2005-05-03 2010-05-25 Boehringer Ingelheim International Gmbh Crystalline forms of 1-chloro-4-(β-D-glucopyranos-1-yl)-2-[4-((R)-tetrahydrofuran-3-yloxy)-benzyl]-benzene, a method for its preparation and the use thereof for preparing medicaments
UA91546C2 (uk) * 2005-05-03 2010-08-10 Бьорінгер Інгельхайм Інтернаціональ Гмбх КРИСТАЛІЧНА ФОРМА 1-ХЛОР-4-(β-D-ГЛЮКОПІРАНОЗ-1-ИЛ)-2-[4-((S)-ТЕТРАГІДРОФУРАН-3-ІЛОКСИ)-БЕНЗИЛ]-БЕНЗОЛУ, СПОСІБ ЇЇ ОДЕРЖАННЯ ТА ЇЇ ЗАСТОСУВАННЯ ПРИ ПРИГОТУВАННІ ЛІКАРСЬКИХ ЗАСОБІВ
US7772191B2 (en) 2005-05-10 2010-08-10 Boehringer Ingelheim International Gmbh Processes for preparing of glucopyranosyl-substituted benzyl-benzene derivatives and intermediates therein
WO2007000445A1 (en) 2005-06-29 2007-01-04 Boehringer Ingelheim International Gmbh Glucopyranosyl-substituted benzyl-benzene derivatives, medicaments containing such compounds, their use and process for their manufacture
AR054871A1 (es) 2005-07-27 2007-07-25 Boehringer Ingelheim Int Derivados de (hetero)cicloalquiletinil-bencil)-benceno sustituidos con glucopiranosilo, medicamentos que contienen dichos compuestos, sus uso y proceso para su fabricacion
WO2007025943A2 (en) 2005-08-30 2007-03-08 Boehringer Ingelheim International Gmbh Glucopyranosyl-substituted benzyl-benzene derivatives, medicaments containing such compounds, their use and process for their manufacture
AU2006289093A1 (en) 2005-09-08 2007-03-15 Boehringer Ingelheim International Gmbh Crystalline forms of 1-chloro-4-(beta-D-glucopyranos-1-yl)-2-(4-ethynyl-benzyl)-benzene, methods for its preparation and the use thereof for preparing medicaments
AR056195A1 (es) 2005-09-15 2007-09-26 Boehringer Ingelheim Int Procedimientos para preparar derivados de (etinil-bencil)-benceno sustituidos de glucopiranosilo y compuestos intermedios de los mismos
AR059489A1 (es) 2006-02-15 2008-04-09 Boehringer Ingelheim Vetmed Derivados de benzonitrilo sustituidos con glucopiranosilo, composiciones farmaceuticas que contienen compuestos de este tipo, su uso y procedimiento para su fabricacion
PE20080697A1 (es) 2006-05-03 2008-08-05 Boehringer Ingelheim Int Derivados de benzonitrilo sustituidos con glucopiranosilo, composiciones farmaceuticas que contienen compuestos de este tipo, su uso y procedimiento para su fabricacion
PE20080251A1 (es) * 2006-05-04 2008-04-25 Boehringer Ingelheim Int Usos de inhibidores de dpp iv
WO2008020011A1 (en) * 2006-08-15 2008-02-21 Boehringer Ingelheim International Gmbh Glucopyranosyl-substituted cyclopropylbenzene derivatives, pharmaceutical compositions containing such compounds, their use as sglt inhibitors and process for their manufacture
WO2008034859A1 (en) * 2006-09-21 2008-03-27 Boehringer Ingelheim International Gmbh Glucopyranosyl-substituted difluorobenzyl-benzene derivatives, medicaments containing such compounds, their use and process for their manufacture
WO2008049923A1 (en) * 2006-10-27 2008-05-02 Boehringer Ingelheim International Gmbh CRYSTALLINE FORM OF 4-(ß-D-GLUCOPYRANOS-1-YL)-1-METHYL-2-[4-((S)-TETRAHYDROFURAN-3-YLOXY)-BENZYL]-BENZENE, A METHOD FOR ITS PREPARATION AND THE USE THEREOF FOR PREPARING MEDICAMENTS
CA2668623A1 (en) * 2006-11-06 2008-05-15 Boehringer Ingelheim International Gmbh Glucopyranosyl-substituted benzyl-benzonitrile derivatives, medicaments containing such compounds, their use and process for their manufacture
AU2007316613B2 (en) * 2006-11-09 2013-11-28 Boehringer Ingelheim International Gmbh Combination therapy with SGLT-2 inhibitors and their pharmaceutical compositions
EP2382972A1 (en) * 2007-01-26 2011-11-02 Boehringer Ingelheim International GmbH Methods for preventing and treating neurodegenerative disorders
WO2008101939A1 (en) * 2007-02-21 2008-08-28 Boehringer Ingelheim International Gmbh Tetrasubstituted glucopyranosylated benzene derivatives, medicaments containing such compounds, their use and process for their manufacture
TW200904454A (en) * 2007-03-22 2009-02-01 Bristol Myers Squibb Co Methods for treating obesity employing an SGLT2 inhibitor and compositions thereof
TW200904405A (en) * 2007-03-22 2009-02-01 Bristol Myers Squibb Co Pharmaceutical formulations containing an SGLT2 inhibitor
US20080287529A1 (en) * 2007-05-18 2008-11-20 Bristol-Myers Squibb Company Crystal structures of sglt2 inhibitors and processes for preparing same
UY32427A (es) * 2009-02-13 2010-09-30 Boheringer Ingelheim Internat Gmbh Composicion farmaceutica, forma farmaceutica, procedimiento para su preparacion, metodos de tratamiento y usos de la misma
US20110014284A1 (en) * 2009-02-13 2011-01-20 Boehringer Ingelheim International Gmbh Pharmaceutical composition, pharmaceutical dosage form, process for their preparation, methods for treating and uses thereof
JP5685550B2 (ja) * 2009-02-13 2015-03-18 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Ｓｇｌｔ２阻害剤、ｄｐｐ−ｉｖ阻害剤、更に必要により抗糖尿病薬を含む医薬組成物及びその使用
DK2396005T3 (da) * 2009-02-13 2026-02-09 Boehringer Ingelheim Int Sglt2 hæmmer til at forbedre glykæmisk kontrol
PT2486029E (pt) * 2009-09-30 2015-10-14 Boehringer Ingelheim Int Processos para a preparação de derivados de benzil-benzeno substituídos com glucopiranosilo
EA020798B1 (ru) * 2009-09-30 2015-01-30 Бёрингер Ингельхайм Интернациональ Гмбх СПОСОБ ПОЛУЧЕНИЯ КРИСТАЛЛИЧЕСКОЙ ФОРМЫ 1-ХЛОР-4-(β-D-ГЛЮКОПИРАНОЗ-1-ИЛ)-2-[4-((S)-ТЕТРАГИДРОФУРАН-3-ИЛОКСИ)БЕНЗИЛ]БЕНЗОЛА
UY32919A (es) * 2009-10-02 2011-04-29 Boehringer Ingelheim Int Composición farmacéutica, forma de dosificación farmacéutica, procedimiento para su preparación, mé todos para su tratamiento y sus usos

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1385856A2 (en) * 2001-04-11 2004-02-04 Bristol-Myers Squibb Company Amino acid complexes of c-aryl glucosides for treatment of diabetes and method

Also Published As

Publication number Publication date
BRPI0610994B1 (pt) 2020-08-25
AU2006243859A1 (en) 2006-11-09
MY142108A (en) 2010-09-15
NO339073B1 (no) 2016-11-07
DK1888552T3 (da) 2010-04-12
PE20061374A1 (es) 2007-01-09
KR20080015424A (ko) 2008-02-19
TW200716586A (en) 2007-05-01
HK1115133A1 (en) 2008-11-21
RS51216B (sr) 2010-12-31
HRP20100033T1 (hr) 2010-03-31
EA200702346A1 (ru) 2008-04-28
TWI344465B (en) 2011-07-01
EP1888552B1 (en) 2009-12-23
PL1888552T3 (pl) 2010-06-30
ZA200705883B (en) 2008-09-25
NZ563563A (en) 2010-11-26
CN101155794A (zh) 2008-04-02
UY29505A1 (es) 2006-11-30
NO20073875L (no) 2007-10-18
JP2008540373A (ja) 2008-11-20
US7713938B2 (en) 2010-05-11
ME01173B (me) 2013-03-20
JP2009046513A (ja) 2009-03-05
MX2007013144A (es) 2008-01-21
IL187087A (en) 2011-06-30
EA013079B1 (ru) 2010-02-26
SI1888552T1 (sl) 2010-04-30
AU2006243859B2 (en) 2011-09-29
US20100099641A1 (en) 2010-04-22
WO2006117359A1 (en) 2006-11-09
PE20091063A1 (es) 2009-08-19
JP4226070B2 (ja) 2009-02-18
CY1109870T1 (el) 2014-09-10
ES2337498T3 (es) 2010-04-26
US20070249544A1 (en) 2007-10-25
IL187087A0 (en) 2008-02-09
BRPI0610994A2 (pt) 2010-08-10
PT1888552E (pt) 2010-03-02
UA91546C2 (uk) 2010-08-10
ATE452883T1 (de) 2010-01-15
CA2606650C (en) 2014-02-11
AU2006243859B8 (en) 2011-11-10
BRPI0610994B8 (pt) 2021-05-25
CA2606650A1 (en) 2006-11-09
AR087208A2 (es) 2014-02-26
EP2166007A1 (en) 2010-03-24
EP1888552A1 (en) 2008-02-20
DE602006011310D1 (de) 2010-02-04
AR053720A1 (es) 2007-05-16
CN101155794B (zh) 2011-05-11

Similar Documents

Publication Publication Date Title
KR101249711B1 (ko) 1-클로로-4-(β-Ｄ-글루코피라노스-1-일)-2-［4-((Ｓ)-테트라하이드로푸란-3-일옥시)-벤질］-벤젠의 결정형, 이의 제조방법 및 약제 제조를 위한 이의 용도
EP1888551B1 (en) Crystalline forms of 1-chloro-4-(beta-d-glucopyranos-1-yl)-2-[4-((r)-tetrahydrofuran-3-yloxy)-benzyl]-benzene, a method for its preparation and the use thereof for preparing medicaments
EP1926720B1 (en) CRYSTALLINE FORMS OF 1-CHLORO-4-(ß-D-GLUCOPYRANOS-1-YL)-2-(4-ETHYNYL-BENZYL)-BENZENE, METHODS FOR ITS PREPARATION AND THE USE THEREOF FOR PREPARING MEDICAMENTS
US8283326B2 (en) Crystalline form of 4-(beta-D-glucopyranos-1-yl)-1-methyl-2-[4-((S)-tetrahydrofuran-3-yloxy)-benzyl]-benzene, a method for its preparation and the use thereof for preparing medicaments
HK1115133B (en) CRYSTALLINE FORM OF 1-CHLORO-4-(β-D-GLUCOPYRANOS-1-YL)-2-[4-((S)-TETRAHYDROFURAN-3-YLOXY)-BENZYL]-BENZENE, A METHOD FOR ITS PREPARATION AND THE USE THEREOF FOR PREPARING MEDICAMENTS

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20071203

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20100528

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20111230

Patent event code: PE09021S01D

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20120827

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20130228

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20130327

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20130328

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
A101 Application to extend term of patent right by permit
PA0101 Application to register extension of term of patent right by permit, etc.

Patent event date: 20141112

Patent event code: PA01011R01D

Comment text: Application to Register Extension of Term of Patent Right by Permit, etc.

J204 Request for invalidation trial [patent]
PJ0204 Invalidation trial for patent

Appeal kind category: Invalidation

Request date: 20150327

Decision date: 20160621

Appeal identifier: 2015100001551

Patent event date: 20150327

Comment text: Request for Trial

Patent event code: PJ02042R01D

Patent event date: 20130327

Comment text: Registration of Establishment

Patent event code: PJ02041E01I

Appeal kind category: Invalidation

Request date: 20150327

Decision date: 20170615

Appeal identifier: 2015100001502

J204 Request for invalidation trial [patent]
PJ0204 Invalidation trial for patent

Patent event date: 20150328

Comment text: Request for Trial

Patent event code: PJ02042R01D

Patent event date: 20130327

Comment text: Registration of Establishment

Patent event code: PJ02041E01I

Appeal kind category: Invalidation

Request date: 20150328

Decision date: 20171201

Appeal identifier: 2015100001646

J204 Request for invalidation trial [patent]
PJ0204 Invalidation trial for patent

Patent event date: 20150330

Comment text: Request for Trial

Patent event code: PJ02042R01D

Patent event date: 20130327

Comment text: Registration of Establishment

Patent event code: PJ02041E01I

Appeal kind category: Invalidation

Request date: 20150330

Decision date: 20171201

Appeal identifier: 2015100001705

J204 Request for invalidation trial [patent]
PJ0204 Invalidation trial for patent

Appeal kind category: Invalidation

Request date: 20150403

Decision date: 20151216

Appeal identifier: 2015100002066

Appeal kind category: Invalidation

Request date: 20150403

Decision date: 20171122

Appeal identifier: 2015100001925

Appeal kind category: Invalidation

Request date: 20150403

Decision date: 20151014

Appeal identifier: 2015100001920

Patent event date: 20150403

Comment text: Request for Trial

Patent event code: PJ02042R01D

Patent event date: 20130327

Comment text: Registration of Establishment

Patent event code: PJ02041E01I

Appeal kind category: Invalidation

Request date: 20150403

Decision date: 20171122

Appeal identifier: 2015100001882

J204 Request for invalidation trial [patent]
PJ0204 Invalidation trial for patent

Patent event date: 20150409

Comment text: Request for Trial

Patent event code: PJ02042R01D

Patent event date: 20130327

Comment text: Registration of Establishment

Patent event code: PJ02041E01I

Appeal kind category: Invalidation

Request date: 20150409

Decision date: 20171122

Appeal identifier: 2015100002279

J204 Request for invalidation trial [patent]
PJ0204 Invalidation trial for patent

Appeal kind category: Invalidation

Request date: 20150410

Decision date: 20150706

Appeal identifier: 2015100002593

Appeal kind category: Invalidation

Request date: 20150410

Decision date: 20171201

Appeal identifier: 2015100002456

Patent event date: 20150410

Comment text: Request for Trial

Patent event code: PJ02042R01D

Patent event date: 20130327

Comment text: Registration of Establishment

Patent event code: PJ02041E01I

Appeal kind category: Invalidation

Request date: 20150410

Decision date: 20150617

Appeal identifier: 2015100002453

J121 Written withdrawal of request for trial
PJ1201 Withdrawal of trial

Patent event code: PJ12011R01D

Patent event date: 20150617

Comment text: Written Withdrawal of Request for Trial

Appeal identifier: 2015100002453

Request date: 20150410

Appeal kind category: Invalidation

Decision date: 20150617

J206 Request for trial to confirm the scope of a patent right
PJ0206 Trial to confirm the scope of a patent

Patent event code: PJ02062R01D

Patent event date: 20150701

Comment text: Request for Trial

Patent event code: PJ02061E01I

Patent event date: 20130327

Comment text: Registration of Establishment

Decision date: 20180518

Request date: 20150701

Appeal identifier: 2015100003747

Appeal kind category: Confirmation of the scope of right_defensive

J121 Written withdrawal of request for trial
PJ1201 Withdrawal of trial

Patent event code: PJ12011R01D

Patent event date: 20150706

Comment text: Written Withdrawal of Request for Trial

Appeal identifier: 2015100002593

Request date: 20150410

Appeal kind category: Invalidation

Decision date: 20150706

J121 Written withdrawal of request for trial
PJ1201 Withdrawal of trial

Patent event code: PJ12011R01D

Patent event date: 20151014

Comment text: Written Withdrawal of Request for Trial

Appeal identifier: 2015100001920

Request date: 20150403

Appeal kind category: Invalidation

Decision date: 20151014

J121 Written withdrawal of request for trial
PJ1201 Withdrawal of trial

Patent event code: PJ12011R01D

Patent event date: 20151216

Comment text: Written Withdrawal of Request for Trial

Appeal identifier: 2015100002066

Request date: 20150403

Appeal kind category: Invalidation

Decision date: 20151216

FPAY Annual fee payment

Payment date: 20160322

Year of fee payment: 4

PR1001 Payment of annual fee

Payment date: 20160322

Start annual number: 4

End annual number: 4

J206 Request for trial to confirm the scope of a patent right
PJ0206 Trial to confirm the scope of a patent

Patent event code: PJ02062R01D

Patent event date: 20160613

Comment text: Request for Trial

Patent event code: PJ02061E01I

Patent event date: 20130327

Comment text: Registration of Establishment

Decision date: 20180518

Request date: 20160613

Appeal identifier: 2016100001576

Appeal kind category: Confirmation of the scope of right_defensive

J121 Written withdrawal of request for trial
PJ1201 Withdrawal of trial

Patent event code: PJ12011R01D

Patent event date: 20160621

Comment text: Written Withdrawal of Request for Trial

Appeal identifier: 2015100001551

Request date: 20150327

Appeal kind category: Invalidation

Decision date: 20160621

FPAY Annual fee payment

Payment date: 20170317

Year of fee payment: 5

PR1001 Payment of annual fee

Payment date: 20170317

Start annual number: 5

End annual number: 5

J121 Written withdrawal of request for trial
PJ1201 Withdrawal of trial

Patent event code: PJ12011R01D

Patent event date: 20170615

Comment text: Written Withdrawal of Request for Trial

Appeal identifier: 2015100001502

Request date: 20150327

Appeal kind category: Invalidation

Decision date: 20170615

J301 Trial decision

Free format text: TRIAL NUMBER: 2015100001882; TRIAL DECISION FOR INVALIDATION REQUESTED 20150403

Effective date: 20171122

Free format text: TRIAL NUMBER: 2015100001925; TRIAL DECISION FOR INVALIDATION REQUESTED 20150403

Effective date: 20171122

Free format text: TRIAL NUMBER: 2015100002279; TRIAL DECISION FOR INVALIDATION REQUESTED 20150409

Effective date: 20171122

PJ1301 Trial decision

Appeal kind category: Invalidation

Request date: 20150409

Decision date: 20171122

Appeal identifier: 2015100002279

Appeal kind category: Invalidation

Request date: 20150403

Decision date: 20171122

Appeal identifier: 2015100001925

Patent event code: PJ13011S08D

Patent event date: 20171122

Comment text: Consolidated Trial Decision

Appeal kind category: Invalidation

Request date: 20150403

Decision date: 20171122

Appeal identifier: 2015100001882

J301 Trial decision

Free format text: TRIAL NUMBER: 2015100001705; TRIAL DECISION FOR INVALIDATION REQUESTED 20150330

Effective date: 20171201

PJ1301 Trial decision

Patent event code: PJ13011S05D

Patent event date: 20171201

Comment text: Trial Decision on Invalidation (Patent, Utility Model, Industrial Design)

Appeal kind category: Invalidation

Request date: 20150330

Decision date: 20171201

Appeal identifier: 2015100001705

J301 Trial decision

Free format text: TRIAL NUMBER: 2015100001646; TRIAL DECISION FOR INVALIDATION REQUESTED 20150328

Effective date: 20171201

PJ1301 Trial decision

Appeal kind category: Invalidation

Request date: 20150410

Decision date: 20171201

Appeal identifier: 2015100002456

Patent event code: PJ13011S05D

Patent event date: 20171204

Comment text: Trial Decision on Invalidation (Patent, Utility Model, Industrial Design)

Appeal kind category: Invalidation

Request date: 20150328

Decision date: 20171201

Appeal identifier: 2015100001646

PJ0206 Trial to confirm the scope of a patent

Decision date: 20190523

Request date: 20180115

Appeal identifier: 2018100000142

Appeal kind category: Confirmation of the scope of right_defensive

Patent event code: PJ02062R01D

Patent event date: 20180115

Comment text: Request for Trial

Patent event code: PJ02061E01I

Patent event date: 20130327

Comment text: Registration of Establishment

Decision date: 20190523

Request date: 20180115

Appeal identifier: 2018100000141

Appeal kind category: Confirmation of the scope of right_defensive

PG1701 Publication of correction

Publication date: 20180322

FPAY Annual fee payment

Payment date: 20180316

Year of fee payment: 6

PR1001 Payment of annual fee

Payment date: 20180316

Start annual number: 6

End annual number: 6

PG1701 Publication of correction

Publication date: 20180322

PG1701 Publication of correction

Publication date: 20180322

J301 Trial decision

Free format text: TRIAL NUMBER: 2015100003747; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20150701

Effective date: 20180518

PJ1301 Trial decision

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20160613

Decision date: 20180518

Appeal identifier: 2016100001576

Patent event code: PJ13011S02D

Patent event date: 20180518

Comment text: Trial Decision for Confirmation of the Scope of a Right (Patent, Utility Model, Industrial Design)

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20150701

Decision date: 20180518

Appeal identifier: 2015100003747

PJ2001 Appeal

Appeal kind category: Confirmation of the scope of right_defensive

Decision date: 20200429

Appeal identifier: 2018200005655

Request date: 20180710

Patent event date: 20180518

Comment text: Trial Decision for Confirmation of the Scope of a Right (Patent, Utility Model, Industrial Design)

Patent event code: PJ20011S02I

Patent event date: 20171204

Comment text: Trial Decision on Invalidation (Patent, Utility Model, Industrial Design)

Patent event code: PJ20011S05I

Patent event date: 20171201

Comment text: Trial Decision on Invalidation (Patent, Utility Model, Industrial Design)

Patent event code: PJ20011S05I

Patent event date: 20171122

Comment text: Consolidated Trial Decision

Patent event code: PJ20011S08I

Appeal kind category: Confirmation of the scope of right_defensive

Decision date: 20200429

Appeal identifier: 2018200005648

Request date: 20180710

PR1001 Payment of annual fee

Payment date: 20190315

Start annual number: 7

End annual number: 7

J301 Trial decision

Free format text: TRIAL NUMBER: 2018100000141; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20180115

Effective date: 20190523

Free format text: TRIAL NUMBER: 2018100000142; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20180115

Effective date: 20190523

PJ1301 Trial decision

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20180115

Decision date: 20190523

Appeal identifier: 2018100000142

Patent event code: PJ13011S02D

Patent event date: 20190523

Comment text: Trial Decision for Confirmation of the Scope of a Right (Patent, Utility Model, Industrial Design)

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20180115

Decision date: 20190523

Appeal identifier: 2018100000141

J206 Request for trial to confirm the scope of a patent right
PJ0206 Trial to confirm the scope of a patent

Patent event code: PJ02062R01D

Patent event date: 20190625

Comment text: Request for Trial

Patent event code: PJ02061E01I

Patent event date: 20130327

Comment text: Registration of Establishment

Decision date: 20191230

Request date: 20190625

Appeal identifier: 2019100002064

Appeal kind category: Confirmation of the scope of right_defensive

J206 Request for trial to confirm the scope of a patent right
PJ0206 Trial to confirm the scope of a patent

Patent event code: PJ02062R01D

Patent event date: 20190729

Comment text: Request for Trial

Patent event code: PJ02061E01I

Patent event date: 20130327

Comment text: Registration of Establishment

Decision date: 20200102

Request date: 20190729

Appeal identifier: 2019100002433

Appeal kind category: Confirmation of the scope of right_defensive

J206 Request for trial to confirm the scope of a patent right
PJ0206 Trial to confirm the scope of a patent

Patent event code: PJ02062R01D

Patent event date: 20190809

Comment text: Request for Trial

Patent event code: PJ02061E01I

Patent event date: 20130327

Comment text: Registration of Establishment

Decision date: 20191230

Request date: 20190809

Appeal identifier: 2019100002575

Appeal kind category: Confirmation of the scope of right_defensive

J206 Request for trial to confirm the scope of a patent right
PJ0206 Trial to confirm the scope of a patent

Patent event code: PJ02062R01D

Patent event date: 20190827

Comment text: Request for Trial

Patent event code: PJ02061E01I

Patent event date: 20130327

Comment text: Registration of Establishment

Decision date: 20200320

Request date: 20190827

Appeal identifier: 2019100002745

Appeal kind category: Confirmation of the scope of right_defensive

J206 Request for trial to confirm the scope of a patent right
PJ0206 Trial to confirm the scope of a patent

Decision date: 20191230

Request date: 20190909

Appeal identifier: 2019100002905

Appeal kind category: Confirmation of the scope of right_defensive

Patent event code: PJ02062R01D

Patent event date: 20190909

Comment text: Request for Trial

Patent event code: PJ02061E01I

Patent event date: 20130327

Comment text: Registration of Establishment

Decision date: 20191230

Request date: 20190909

Appeal identifier: 2019100002904

Appeal kind category: Confirmation of the scope of right_defensive

J206 Request for trial to confirm the scope of a patent right
PJ0206 Trial to confirm the scope of a patent

Decision date: 20200320

Request date: 20190920

Appeal identifier: 2019100002989

Appeal kind category: Confirmation of the scope of right_defensive

Decision date: 20200320

Request date: 20190920

Appeal identifier: 2019100002988

Appeal kind category: Confirmation of the scope of right_defensive

Patent event code: PJ02062R01D

Patent event date: 20190920

Comment text: Request for Trial

Patent event code: PJ02061E01I

Patent event date: 20130327

Comment text: Registration of Establishment

Decision date: 20200320

Request date: 20190920

Appeal identifier: 2019100002983

Appeal kind category: Confirmation of the scope of right_defensive

J206 Request for trial to confirm the scope of a patent right
PJ0206 Trial to confirm the scope of a patent

Decision date: 20200320

Request date: 20190927

Appeal identifier: 2019100003053

Appeal kind category: Confirmation of the scope of right_defensive

Patent event code: PJ02062R01D

Patent event date: 20190927

Comment text: Request for Trial

Patent event code: PJ02061E01I

Patent event date: 20130327

Comment text: Registration of Establishment

Decision date: 20200320

Request date: 20190927

Appeal identifier: 2019100003052

Appeal kind category: Confirmation of the scope of right_defensive

J206 Request for trial to confirm the scope of a patent right
PJ0206 Trial to confirm the scope of a patent

Decision date: 20200320

Request date: 20191011

Appeal identifier: 2019100003185

Appeal kind category: Confirmation of the scope of right_defensive

Patent event code: PJ02062R01D

Patent event date: 20191011

Comment text: Request for Trial

Patent event code: PJ02061E01I

Patent event date: 20130327

Comment text: Registration of Establishment

Decision date: 20200320

Request date: 20191011

Appeal identifier: 2019100003184

Appeal kind category: Confirmation of the scope of right_defensive

J206 Request for trial to confirm the scope of a patent right
PJ0206 Trial to confirm the scope of a patent

Patent event code: PJ02062R01D

Patent event date: 20191205

Comment text: Request for Trial

Patent event code: PJ02061E01I

Patent event date: 20130327

Comment text: Registration of Establishment

Decision date: 20200320

Request date: 20191205

Appeal identifier: 2019100003883

Appeal kind category: Confirmation of the scope of right_defensive

J206 Request for trial to confirm the scope of a patent right
PJ0206 Trial to confirm the scope of a patent

Patent event code: PJ02062R01D

Patent event date: 20191211

Comment text: Request for Trial

Patent event code: PJ02061E01I

Patent event date: 20130327

Comment text: Registration of Establishment

Decision date: 20200323

Request date: 20191211

Appeal identifier: 2019100003957

Appeal kind category: Confirmation of the scope of right_defensive

J121 Written withdrawal of request for trial
PJ1201 Withdrawal of trial

Appeal identifier: 2019100002905

Request date: 20190909

Appeal kind category: Confirmation of the scope of right_defensive

Decision date: 20191230

Appeal identifier: 2019100002904

Request date: 20190909

Appeal kind category: Confirmation of the scope of right_defensive

Decision date: 20191230

Appeal identifier: 2019100002575

Request date: 20190809

Appeal kind category: Confirmation of the scope of right_defensive

Decision date: 20191230

Patent event code: PJ12011R01D

Patent event date: 20191230

Comment text: Written Withdrawal of Request for Trial

Appeal identifier: 2019100002064

Request date: 20190625

Appeal kind category: Confirmation of the scope of right_defensive

Decision date: 20191230

J121 Written withdrawal of request for trial
PJ1201 Withdrawal of trial

Patent event code: PJ12011R01D

Patent event date: 20200102

Comment text: Written Withdrawal of Request for Trial

Appeal identifier: 2019100002433

Request date: 20190729

Appeal kind category: Confirmation of the scope of right_defensive

Decision date: 20200102

J206 Request for trial to confirm the scope of a patent right
PJ0206 Trial to confirm the scope of a patent

Patent event code: PJ02062R01D

Patent event date: 20200110

Comment text: Request for Trial

Patent event code: PJ02061E01I

Patent event date: 20130327

Comment text: Registration of Establishment

Decision date: 20200323

Request date: 20200110

Appeal identifier: 2020100000087

Appeal kind category: Confirmation of the scope of right_defensive

J206 Request for trial to confirm the scope of a patent right
PJ0206 Trial to confirm the scope of a patent

Patent event code: PJ02062R01D

Patent event date: 20200214

Comment text: Request for Trial

Patent event code: PJ02061E01I

Patent event date: 20130327

Comment text: Registration of Establishment

Decision date: 20200323

Request date: 20200214

Appeal identifier: 2020100000499

Appeal kind category: Confirmation of the scope of right_defensive

J206 Request for trial to confirm the scope of a patent right
PJ0206 Trial to confirm the scope of a patent

Decision date: 20200601

Request date: 20200309

Appeal identifier: 2020100000762

Appeal kind category: Confirmation of the scope of right_defensive

Patent event code: PJ02062R01D

Patent event date: 20200309

Comment text: Request for Trial

Patent event code: PJ02061E01I

Patent event date: 20130327

Comment text: Registration of Establishment

Decision date: 20200601

Request date: 20200309

Appeal identifier: 2020100000761

Appeal kind category: Confirmation of the scope of right_defensive

J206 Request for trial to confirm the scope of a patent right
PJ0206 Trial to confirm the scope of a patent

Patent event code: PJ02062R01D

Patent event date: 20200310

Comment text: Request for Trial

Patent event code: PJ02061E01I

Patent event date: 20130327

Comment text: Registration of Establishment

Decision date: 20200601

Request date: 20200310

Appeal identifier: 2020100000767

Appeal kind category: Confirmation of the scope of right_defensive

J206 Request for trial to confirm the scope of a patent right
PJ0206 Trial to confirm the scope of a patent

Patent event code: PJ02062R01D

Patent event date: 20200311

Comment text: Request for Trial

Patent event code: PJ02061E01I

Patent event date: 20130327

Comment text: Registration of Establishment

Decision date: 20200601

Request date: 20200311

Appeal identifier: 2020100000799

Appeal kind category: Confirmation of the scope of right_defensive

J206 Request for trial to confirm the scope of a patent right
PJ0206 Trial to confirm the scope of a patent

Decision date: 20200601

Request date: 20200318

Appeal identifier: 2020100000882

Appeal kind category: Confirmation of the scope of right_defensive

Decision date: 20200601

Request date: 20200318

Appeal identifier: 2020100000881

Appeal kind category: Confirmation of the scope of right_defensive

Patent event code: PJ02062R01D

Patent event date: 20200318

Comment text: Request for Trial

Patent event code: PJ02061E01I

Patent event date: 20130327

Comment text: Registration of Establishment

Decision date: 20200601

Request date: 20200318

Appeal identifier: 2020100000880

Appeal kind category: Confirmation of the scope of right_defensive

J206 Request for trial to confirm the scope of a patent right
PJ0206 Trial to confirm the scope of a patent

Decision date: 20200601

Request date: 20200319

Appeal identifier: 2020100000899

Appeal kind category: Confirmation of the scope of right_defensive

Decision date: 20200601

Request date: 20200319

Appeal identifier: 2020100000898

Appeal kind category: Confirmation of the scope of right_defensive

Patent event code: PJ02062R01D

Patent event date: 20200319

Comment text: Request for Trial

Patent event code: PJ02061E01I

Patent event date: 20130327

Comment text: Registration of Establishment

Decision date: 20200601

Request date: 20200319

Appeal identifier: 2020100000897

Appeal kind category: Confirmation of the scope of right_defensive

J206 Request for trial to confirm the scope of a patent right
J301 Trial decision

Free format text: TRIAL NUMBER: 2019100002745; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20190827

Effective date: 20200320

Free format text: TRIAL NUMBER: 2019100002989; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20190920

Effective date: 20200320

Free format text: TRIAL NUMBER: 2019100003052; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20190927

Effective date: 20200320

Free format text: TRIAL NUMBER: 2019100002983; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20190920

Effective date: 20200320

Free format text: TRIAL NUMBER: 2019100003184; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20191011

Effective date: 20200320

Free format text: TRIAL NUMBER: 2019100003053; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20190927

Effective date: 20200320

Free format text: TRIAL NUMBER: 2019100002988; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20190920

Effective date: 20200320

Free format text: TRIAL NUMBER: 2019100003185; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20191011

Effective date: 20200320

Free format text: TRIAL NUMBER: 2019100003883; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20191205

Effective date: 20200320

PJ0206 Trial to confirm the scope of a patent

Decision date: 20200515

Request date: 20200320

Appeal identifier: 2020100000919

Appeal kind category: Confirmation of the scope of right_defensive

Decision date: 20200601

Request date: 20200320

Appeal identifier: 2020100000918

Appeal kind category: Confirmation of the scope of right_defensive

Patent event code: PJ02062R01D

Patent event date: 20200320

Comment text: Request for Trial

Patent event code: PJ02061E01I

Patent event date: 20130327

Comment text: Registration of Establishment

Decision date: 20200601

Request date: 20200320

Appeal identifier: 2020100000917

Appeal kind category: Confirmation of the scope of right_defensive

PJ1301 Trial decision

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20191205

Decision date: 20200320

Appeal identifier: 2019100003883

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20191011

Decision date: 20200320

Appeal identifier: 2019100003185

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20191011

Decision date: 20200320

Appeal identifier: 2019100003184

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20190927

Decision date: 20200320

Appeal identifier: 2019100003053

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20190927

Decision date: 20200320

Appeal identifier: 2019100003052

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20190920

Decision date: 20200320

Appeal identifier: 2019100002989

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20190920

Decision date: 20200320

Appeal identifier: 2019100002988

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20190920

Decision date: 20200320

Appeal identifier: 2019100002983

Patent event code: PJ13011S02D

Patent event date: 20200320

Comment text: Trial Decision for Confirmation of the Scope of a Right (Patent, Utility Model, Industrial Design)

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20190827

Decision date: 20200320

Appeal identifier: 2019100002745

PR1001 Payment of annual fee

Payment date: 20200320

Start annual number: 8

End annual number: 8

J301 Trial decision

Free format text: TRIAL NUMBER: 2020100000087; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20200110

Effective date: 20200323

Free format text: TRIAL NUMBER: 2019100003957; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20191211

Effective date: 20200323

Free format text: TRIAL NUMBER: 2020100000499; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20200214

Effective date: 20200323

PJ1301 Trial decision

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20200214

Decision date: 20200323

Appeal identifier: 2020100000499

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20200110

Decision date: 20200323

Appeal identifier: 2020100000087

Patent event code: PJ13011S02D

Patent event date: 20200323

Comment text: Trial Decision for Confirmation of the Scope of a Right (Patent, Utility Model, Industrial Design)

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20191211

Decision date: 20200323

Appeal identifier: 2019100003957

J206 Request for trial to confirm the scope of a patent right
PJ0206 Trial to confirm the scope of a patent

Patent event code: PJ02062R01D

Patent event date: 20200324

Comment text: Request for Trial

Patent event code: PJ02061E01I

Patent event date: 20130327

Comment text: Registration of Establishment

Decision date: 20200601

Request date: 20200324

Appeal identifier: 2020100000941

Appeal kind category: Confirmation of the scope of right_defensive

J206 Request for trial to confirm the scope of a patent right
PJ0206 Trial to confirm the scope of a patent

Decision date: 20200601

Request date: 20200325

Appeal identifier: 2020100000970

Appeal kind category: Confirmation of the scope of right_defensive

Patent event code: PJ02062R01D

Patent event date: 20200325

Comment text: Request for Trial

Patent event code: PJ02061E01I

Patent event date: 20130327

Comment text: Registration of Establishment

Decision date: 20200601

Request date: 20200325

Appeal identifier: 2020100000969

Appeal kind category: Confirmation of the scope of right_defensive

J206 Request for trial to confirm the scope of a patent right
PJ0206 Trial to confirm the scope of a patent

Decision date: 20200601

Request date: 20200326

Appeal identifier: 2020100000995

Appeal kind category: Confirmation of the scope of right_defensive

Decision date: 20200601

Request date: 20200326

Appeal identifier: 2020100000994

Appeal kind category: Confirmation of the scope of right_defensive

Decision date: 20200601

Request date: 20200326

Appeal identifier: 2020100000993

Appeal kind category: Confirmation of the scope of right_defensive

Patent event code: PJ02062R01D

Patent event date: 20200326

Comment text: Request for Trial

Patent event code: PJ02061E01I

Patent event date: 20130327

Comment text: Registration of Establishment

Decision date: 20200601

Request date: 20200326

Appeal identifier: 2020100000985

Appeal kind category: Confirmation of the scope of right_defensive

J206 Request for trial to confirm the scope of a patent right
PJ0206 Trial to confirm the scope of a patent

Decision date: 20200601

Request date: 20200327

Appeal identifier: 2020100001008

Appeal kind category: Confirmation of the scope of right_defensive

Decision date: 20200327

Request date: 20200327

Appeal identifier: 2020100000999

Appeal kind category: Confirmation of the scope of right_defensive

Decision date: 20200327

Request date: 20200327

Appeal identifier: 2020100000998

Appeal kind category: Confirmation of the scope of right_defensive

Decision date: 20200601

Request date: 20200327

Appeal identifier: 2020100000997

Appeal kind category: Confirmation of the scope of right_defensive

Patent event code: PJ02062R01D

Patent event date: 20200327

Comment text: Request for Trial

Patent event code: PJ02061E01I

Patent event date: 20130327

Comment text: Registration of Establishment

Decision date: 20200601

Request date: 20200327

Appeal identifier: 2020100000996

Appeal kind category: Confirmation of the scope of right_defensive

PJ1201 Withdrawal of trial

Appeal identifier: 2020100000999

Request date: 20200327

Appeal kind category: Confirmation of the scope of right_defensive

Decision date: 20200327

Patent event code: PJ12011R01D

Patent event date: 20200327

Comment text: Written Withdrawal of Request for Trial

Appeal identifier: 2020100000998

Request date: 20200327

Appeal kind category: Confirmation of the scope of right_defensive

Decision date: 20200327

J206 Request for trial to confirm the scope of a patent right
PJ0206 Trial to confirm the scope of a patent

Patent event code: PJ02062R01D

Patent event date: 20200330

Comment text: Request for Trial

Patent event code: PJ02061E01I

Patent event date: 20130327

Comment text: Registration of Establishment

Decision date: 20200601

Request date: 20200330

Appeal identifier: 2020100001031

Appeal kind category: Confirmation of the scope of right_defensive

J206 Request for trial to confirm the scope of a patent right
PJ0206 Trial to confirm the scope of a patent

Patent event code: PJ02062R01D

Patent event date: 20200403

Comment text: Request for Trial

Patent event code: PJ02061E01I

Patent event date: 20130327

Comment text: Registration of Establishment

Decision date: 20200601

Request date: 20200403

Appeal identifier: 2020100001090

Appeal kind category: Confirmation of the scope of right_defensive

J206 Request for trial to confirm the scope of a patent right
PJ0206 Trial to confirm the scope of a patent

Patent event code: PJ02062R01D

Patent event date: 20200406

Comment text: Request for Trial

Patent event code: PJ02061E01I

Patent event date: 20130327

Comment text: Registration of Establishment

Decision date: 20200601

Request date: 20200406

Appeal identifier: 2020100001103

Appeal kind category: Confirmation of the scope of right_defensive

J206 Request for trial to confirm the scope of a patent right
PJ0206 Trial to confirm the scope of a patent

Patent event code: PJ02062R01D

Patent event date: 20200407

Comment text: Request for Trial

Patent event code: PJ02061E01I

Patent event date: 20130327

Comment text: Registration of Establishment

Decision date: 20200601

Request date: 20200407

Appeal identifier: 2020100001110

Appeal kind category: Confirmation of the scope of right_defensive

J206 Request for trial to confirm the scope of a patent right
PJ0206 Trial to confirm the scope of a patent

Decision date: 20200601

Request date: 20200408

Appeal identifier: 2020100001131

Appeal kind category: Confirmation of the scope of right_defensive

Patent event code: PJ02062R01D

Patent event date: 20200408

Comment text: Request for Trial

Patent event code: PJ02061E01I

Patent event date: 20130327

Comment text: Registration of Establishment

Decision date: 20200601

Request date: 20200408

Appeal identifier: 2020100001130

Appeal kind category: Confirmation of the scope of right_defensive

J206 Request for trial to confirm the scope of a patent right
PJ0206 Trial to confirm the scope of a patent

Patent event code: PJ02062R01D

Patent event date: 20200414

Comment text: Request for Trial

Patent event code: PJ02061E01I

Patent event date: 20130327

Comment text: Registration of Establishment

Decision date: 20200601

Request date: 20200414

Appeal identifier: 2020100001207

Appeal kind category: Confirmation of the scope of right_defensive

J206 Request for trial to confirm the scope of a patent right
PJ0206 Trial to confirm the scope of a patent

Decision date: 20200601

Request date: 20200416

Appeal identifier: 2020100001220

Appeal kind category: Confirmation of the scope of right_defensive

Patent event code: PJ02062R01D

Patent event date: 20200416

Comment text: Request for Trial

Patent event code: PJ02061E01I

Patent event date: 20130327

Comment text: Registration of Establishment

Decision date: 20200601

Request date: 20200416

Appeal identifier: 2020100001217

Appeal kind category: Confirmation of the scope of right_defensive

J206 Request for trial to confirm the scope of a patent right
PJ0206 Trial to confirm the scope of a patent

Decision date: 20200601

Request date: 20200417

Appeal identifier: 2020100001243

Appeal kind category: Confirmation of the scope of right_defensive

Patent event code: PJ02062R01D

Patent event date: 20200417

Comment text: Request for Trial

Patent event code: PJ02061E01I

Patent event date: 20130327

Comment text: Registration of Establishment

Decision date: 20200601

Request date: 20200417

Appeal identifier: 2020100001232

Appeal kind category: Confirmation of the scope of right_defensive

J206 Request for trial to confirm the scope of a patent right
PJ0206 Trial to confirm the scope of a patent

Patent event code: PJ02062R01D

Patent event date: 20200420

Comment text: Request for Trial

Patent event code: PJ02061E01I

Patent event date: 20130327

Comment text: Registration of Establishment

Decision date: 20200601

Request date: 20200420

Appeal identifier: 2020100001264

Appeal kind category: Confirmation of the scope of right_defensive

J206 Request for trial to confirm the scope of a patent right
PJ0206 Trial to confirm the scope of a patent

Decision date: 20210105

Request date: 20200429

Appeal identifier: 2020100001378

Appeal kind category: Confirmation of the scope of right_defensive

Decision date: 20210105

Request date: 20200429

Appeal identifier: 2020100001377

Appeal kind category: Confirmation of the scope of right_defensive

Patent event code: PJ02062R01D

Patent event date: 20200429

Comment text: Request for Trial

Patent event code: PJ02061E01I

Patent event date: 20130327

Comment text: Registration of Establishment

Decision date: 20210105

Request date: 20200429

Appeal identifier: 2020100001376

Appeal kind category: Confirmation of the scope of right_defensive

J206 Request for trial to confirm the scope of a patent right
PJ0206 Trial to confirm the scope of a patent

Patent event code: PJ02062R01D

Patent event date: 20200430

Comment text: Request for Trial

Patent event code: PJ02061E01I

Patent event date: 20130327

Comment text: Registration of Establishment

Decision date: 20210105

Request date: 20200430

Appeal identifier: 2020100001379

Appeal kind category: Confirmation of the scope of right_defensive

J122 Written withdrawal of action (patent court)
PJ1202 Withdrawal of action (patent court)

Decision date: 20200429

Request date: 20180710

Appeal identifier: 2018200005655

Appeal kind category: Confirmation of the scope of right_defensive

Patent event code: PJ12021R01D

Patent event date: 20200508

Comment text: Written Withdrawal of Action

Decision date: 20200429

Request date: 20180710

Appeal identifier: 2018200005648

Appeal kind category: Confirmation of the scope of right_defensive

PJ1201 Withdrawal of trial

Patent event code: PJ12011R01D

Patent event date: 20200515

Comment text: Written Withdrawal of Request for Trial

Appeal identifier: 2020100000919

Request date: 20200320

Appeal kind category: Confirmation of the scope of right_defensive

Decision date: 20200515

J301 Trial decision

Free format text: TRIAL NUMBER: 2020100001008; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20200327

Effective date: 20200601

Free format text: TRIAL NUMBER: 2020100000995; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20200326

Effective date: 20200601

Free format text: TRIAL NUMBER: 2020100000997; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20200327

Effective date: 20200601

Free format text: TRIAL NUMBER: 2020100001220; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20200416

Effective date: 20200601

Free format text: TRIAL NUMBER: 2020100001131; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20200408

Effective date: 20200601

Free format text: TRIAL NUMBER: 2020100000799; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20200311

Effective date: 20200601

Free format text: TRIAL NUMBER: 2020100000881; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20200318

Effective date: 20200601

Free format text: TRIAL NUMBER: 2020100001031; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20200330

Effective date: 20200601

Free format text: TRIAL NUMBER: 2020100000897; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20200319

Effective date: 20200601

Free format text: TRIAL NUMBER: 2020100000941; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20200324

Effective date: 20200601

Free format text: TRIAL NUMBER: 2020100000898; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20200319

Effective date: 20200601

Free format text: TRIAL NUMBER: 2020100001207; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20200414

Effective date: 20200601

Free format text: TRIAL NUMBER: 2020100000969; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20200325

Effective date: 20200601

Free format text: TRIAL NUMBER: 2020100000899; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20200319

Effective date: 20200601

Free format text: TRIAL NUMBER: 2020100000985; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20200326

Effective date: 20200601

Free format text: TRIAL NUMBER: 2020100001130; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20200408

Effective date: 20200601

Free format text: TRIAL NUMBER: 2020100001103; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20200406

Effective date: 20200601

Free format text: TRIAL NUMBER: 2020100000767; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20200310

Effective date: 20200601

Free format text: TRIAL NUMBER: 2020100000880; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20200318

Effective date: 20200601

Free format text: TRIAL NUMBER: 2020100000996; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20200327

Effective date: 20200601

Free format text: TRIAL NUMBER: 2020100001232; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20200417

Effective date: 20200601

Free format text: TRIAL NUMBER: 2020100001110; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20200407

Effective date: 20200601

Free format text: TRIAL NUMBER: 2020100001243; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20200417

Effective date: 20200601

Free format text: TRIAL NUMBER: 2020100001217; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20200416

Effective date: 20200601

Free format text: TRIAL NUMBER: 2020100000917; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20200320

Effective date: 20200601

Free format text: TRIAL NUMBER: 2020100000882; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20200318

Effective date: 20200601

Free format text: TRIAL NUMBER: 2020100000918; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20200320

Effective date: 20200601

Free format text: TRIAL NUMBER: 2020100000761; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20200309

Effective date: 20200601

Free format text: TRIAL NUMBER: 2020100000993; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20200326

Effective date: 20200601

Free format text: TRIAL NUMBER: 2020100000762; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20200309

Effective date: 20200601

Free format text: TRIAL NUMBER: 2020100000994; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20200326

Effective date: 20200601

Free format text: TRIAL NUMBER: 2020100001090; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20200403

Effective date: 20200601

Free format text: TRIAL NUMBER: 2020100000970; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20200325

Effective date: 20200601

PJ1301 Trial decision

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20200420

Decision date: 20200601

Appeal identifier: 2020100001264

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20200417

Decision date: 20200601

Appeal identifier: 2020100001243

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20200417

Decision date: 20200601

Appeal identifier: 2020100001232

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20200416

Decision date: 20200601

Appeal identifier: 2020100001220

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20200416

Decision date: 20200601

Appeal identifier: 2020100001217

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20200414

Decision date: 20200601

Appeal identifier: 2020100001207

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20200408

Decision date: 20200601

Appeal identifier: 2020100001131

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20200408

Decision date: 20200601

Appeal identifier: 2020100001130

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20200407

Decision date: 20200601

Appeal identifier: 2020100001110

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20200406

Decision date: 20200601

Appeal identifier: 2020100001103

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20200403

Decision date: 20200601

Appeal identifier: 2020100001090

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20200330

Decision date: 20200601

Appeal identifier: 2020100001031

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20200327

Decision date: 20200601

Appeal identifier: 2020100001008

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20200327

Decision date: 20200601

Appeal identifier: 2020100000997

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20200327

Decision date: 20200601

Appeal identifier: 2020100000996

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20200326

Decision date: 20200601

Appeal identifier: 2020100000995

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20200326

Decision date: 20200601

Appeal identifier: 2020100000994

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20200326

Decision date: 20200601

Appeal identifier: 2020100000993

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20200326

Decision date: 20200601

Appeal identifier: 2020100000985

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20200325

Decision date: 20200601

Appeal identifier: 2020100000970

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20200325

Decision date: 20200601

Appeal identifier: 2020100000969

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20200324

Decision date: 20200601

Appeal identifier: 2020100000941

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20200320

Decision date: 20200601

Appeal identifier: 2020100000918

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20200320

Decision date: 20200601

Appeal identifier: 2020100000917

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20200319

Decision date: 20200601

Appeal identifier: 2020100000899

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20200319

Decision date: 20200601

Appeal identifier: 2020100000898

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20200319

Decision date: 20200601

Appeal identifier: 2020100000897

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20200318

Decision date: 20200601

Appeal identifier: 2020100000882

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20200318

Decision date: 20200601

Appeal identifier: 2020100000881

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20200318

Decision date: 20200601

Appeal identifier: 2020100000880

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20200311

Decision date: 20200601

Appeal identifier: 2020100000799

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20200310

Decision date: 20200601

Appeal identifier: 2020100000767

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20200309

Decision date: 20200601

Appeal identifier: 2020100000762

Patent event code: PJ13011S02D

Patent event date: 20200601

Comment text: Trial Decision for Confirmation of the Scope of a Right (Patent, Utility Model, Industrial Design)

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20200309

Decision date: 20200601

Appeal identifier: 2020100000761

J206 Request for trial to confirm the scope of a patent right
PJ0206 Trial to confirm the scope of a patent

Patent event code: PJ02062R01D

Patent event date: 20200805

Comment text: Request for Trial

Patent event code: PJ02061E01I

Patent event date: 20130327

Comment text: Registration of Establishment

Decision date: 20210106

Request date: 20200805

Appeal identifier: 2020100002350

Appeal kind category: Confirmation of the scope of right_defensive

J206 Request for trial to confirm the scope of a patent right
PJ0206 Trial to confirm the scope of a patent

Patent event code: PJ02062R01D

Patent event date: 20200806

Comment text: Request for Trial

Patent event code: PJ02061E01I

Patent event date: 20130327

Comment text: Registration of Establishment

Decision date: 20210106

Request date: 20200806

Appeal identifier: 2020100002373

Appeal kind category: Confirmation of the scope of right_defensive

J206 Request for trial to confirm the scope of a patent right
PJ0206 Trial to confirm the scope of a patent

Patent event code: PJ02062R01D

Patent event date: 20200810

Comment text: Request for Trial

Patent event code: PJ02061E01I

Patent event date: 20130327

Comment text: Registration of Establishment

Decision date: 20210106

Request date: 20200810

Appeal identifier: 2020100002433

Appeal kind category: Confirmation of the scope of right_defensive

J206 Request for trial to confirm the scope of a patent right
PJ0206 Trial to confirm the scope of a patent

Patent event code: PJ02062R01D

Patent event date: 20200811

Comment text: Request for Trial

Patent event code: PJ02061E01I

Patent event date: 20130327

Comment text: Registration of Establishment

Decision date: 20210416

Request date: 20200811

Appeal identifier: 2020100002453

Appeal kind category: Confirmation of the scope of right_defensive

J206 Request for trial to confirm the scope of a patent right
PJ0206 Trial to confirm the scope of a patent

Patent event code: PJ02062R01D

Patent event date: 20200824

Comment text: Request for Trial

Patent event code: PJ02061E01I

Patent event date: 20130327

Comment text: Registration of Establishment

Decision date: 20210106

Request date: 20200824

Appeal identifier: 2020100002550

Appeal kind category: Confirmation of the scope of right_defensive

J301 Trial decision

Free format text: TRIAL NUMBER: 2020100001377; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20200429

Effective date: 20210105

Free format text: TRIAL NUMBER: 2020100001379; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20200430

Effective date: 20210105

Free format text: TRIAL NUMBER: 2020100001378; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20200429

Effective date: 20210105

Free format text: TRIAL NUMBER: 2020100001376; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20200429

Effective date: 20210105

PJ1301 Trial decision

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20200430

Decision date: 20210105

Appeal identifier: 2020100001379

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20200429

Decision date: 20210105

Appeal identifier: 2020100001378

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20200429

Decision date: 20210105

Appeal identifier: 2020100001377

Patent event code: PJ13011S02D

Patent event date: 20210105

Comment text: Trial Decision for Confirmation of the Scope of a Right (Patent, Utility Model, Industrial Design)

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20200429

Decision date: 20210105

Appeal identifier: 2020100001376

J301 Trial decision

Free format text: TRIAL NUMBER: 2020100002433; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20200810

Effective date: 20210106

Free format text: TRIAL NUMBER: 2020100002350; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20200805

Effective date: 20210106

Free format text: TRIAL NUMBER: 2020100002373; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20200806

Effective date: 20210106

PJ1301 Trial decision

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20200824

Decision date: 20210106

Appeal identifier: 2020100002550

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20200810

Decision date: 20210106

Appeal identifier: 2020100002433

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20200806

Decision date: 20210106

Appeal identifier: 2020100002373

Patent event code: PJ13011S02D

Patent event date: 20210106

Comment text: Trial Decision for Confirmation of the Scope of a Right (Patent, Utility Model, Industrial Design)

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20200805

Decision date: 20210106

Appeal identifier: 2020100002350

PR1001 Payment of annual fee

Payment date: 20210319

Start annual number: 9

End annual number: 9

PJ1301 Trial decision

Patent event code: PJ13011S02D

Patent event date: 20210416

Comment text: Trial Decision for Confirmation of the Scope of a Right (Patent, Utility Model, Industrial Design)

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20200811

Decision date: 20210416

Appeal identifier: 2020100002453

PR1001 Payment of annual fee

Payment date: 20220318

Start annual number: 10

End annual number: 10

J206 Request for trial to confirm the scope of a patent right
PJ0206 Trial to confirm the scope of a patent

Patent event code: PJ02062R01D

Patent event date: 20220623

Comment text: Request for Trial

Patent event code: PJ02061E01I

Patent event date: 20130327

Comment text: Registration of Establishment

Decision date: 20221108

Request date: 20220623

Appeal identifier: 2022100001781

Appeal kind category: Confirmation of the scope of right_defensive

J206 Request for trial to confirm the scope of a patent right
PJ0206 Trial to confirm the scope of a patent

Patent event code: PJ02062R01D

Patent event date: 20220720

Comment text: Request for Trial

Patent event code: PJ02061E01I

Patent event date: 20130327

Comment text: Registration of Establishment

Decision date: 20221108

Request date: 20220720

Appeal identifier: 2022100002043

Appeal kind category: Confirmation of the scope of right_defensive

J301 Trial decision

Free format text: TRIAL NUMBER: 2022100002043; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20220720

Effective date: 20221108

Free format text: TRIAL NUMBER: 2022100001781; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20220623

Effective date: 20221108

PJ1301 Trial decision

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20220720

Decision date: 20221108

Appeal identifier: 2022100002043

Patent event code: PJ13011S02D

Patent event date: 20221108

Comment text: Trial Decision for Confirmation of the Scope of a Right (Patent, Utility Model, Industrial Design)

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20220623

Decision date: 20221108

Appeal identifier: 2022100001781

J206 Request for trial to confirm the scope of a patent right
PJ0206 Trial to confirm the scope of a patent

Patent event code: PJ02062R01D

Patent event date: 20221221

Comment text: Request for Trial

Patent event code: PJ02061E01I

Patent event date: 20130327

Comment text: Registration of Establishment

Request date: 20221221

Appeal identifier: 2022100003537

Appeal kind category: Confirmation of the scope of right_defensive

J301 Trial decision

Free format text: TRIAL NUMBER: 2022100003537; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20221221

Effective date: 20230727

PJ1301 Trial decision

Patent event code: PJ13011S02D

Patent event date: 20230727

Comment text: Trial Decision for Confirmation of the Scope of a Right (Patent, Utility Model, Industrial Design)

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20221221

Decision date: 20230727

Appeal identifier: 2022100003537

J206 Request for trial to confirm the scope of a patent right
PJ0206 Trial to confirm the scope of a patent

Request date: 20230818

Appeal identifier: 2023100002766

Appeal kind category: Confirmation of the scope of right_defensive

Patent event code: PJ02062R01D

Patent event date: 20230818

Comment text: Request for Trial

Patent event code: PJ02061E01I

Patent event date: 20130327

Comment text: Registration of Establishment

Request date: 20230818

Appeal identifier: 2023100002765

Appeal kind category: Confirmation of the scope of right_defensive

J301 Trial decision

Free format text: TRIAL NUMBER: 2023100002765; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20230818

Effective date: 20231030

PJ1301 Trial decision

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20230818

Decision date: 20231030

Appeal identifier: 2023100002766

Patent event code: PJ13011S02D

Patent event date: 20231030

Comment text: Trial Decision for Confirmation of the Scope of a Right (Patent, Utility Model, Industrial Design)

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20230818

Decision date: 20231030

Appeal identifier: 2023100002765

PR1001 Payment of annual fee

Payment date: 20240315

Start annual number: 12

End annual number: 12

J206 Request for trial to confirm the scope of a patent right
PJ0206 Trial to confirm the scope of a patent

Request date: 20240329

Appeal identifier: 2024100000947

Appeal kind category: Confirmation of the scope of right_defensive

Patent event code: PJ02062R01D

Patent event date: 20240329

Comment text: Request for Trial

Patent event code: PJ02061E01I

Patent event date: 20130327

Comment text: Registration of Establishment

Request date: 20240329

Appeal identifier: 2024100000932

Appeal kind category: Confirmation of the scope of right_defensive

J121 Written withdrawal of request for trial
PJ1201 Withdrawal of trial

Patent event code: PJ12011R01D

Patent event date: 20240530

Comment text: Written Withdrawal of Request for Trial

Appeal identifier: 2024100000932

Request date: 20240329

Appeal kind category: Confirmation of the scope of right_defensive

J206 Request for trial to confirm the scope of a patent right
PJ0206 Trial to confirm the scope of a patent

Request date: 20240610

Appeal identifier: 2024100001688

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20240610

Appeal identifier: 2024100001687

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20240610

Appeal identifier: 2024100001686

Appeal kind category: Confirmation of the scope of right_defensive

Patent event code: PJ02062R01D

Patent event date: 20240610

Comment text: Request for Trial

Patent event code: PJ02061E01I

Patent event date: 20130327

Comment text: Registration of Establishment

Request date: 20240610

Appeal identifier: 2024100001685

Appeal kind category: Confirmation of the scope of right_defensive

J206 Request for trial to confirm the scope of a patent right
PJ0206 Trial to confirm the scope of a patent

Patent event code: PJ02062R01D

Patent event date: 20240719

Comment text: Request for Trial

Patent event code: PJ02061E01I

Patent event date: 20130327

Comment text: Registration of Establishment

Request date: 20240719

Appeal identifier: 2024100002157

Appeal kind category: Confirmation of the scope of right_defensive

J301 Trial decision

Free format text: TRIAL NUMBER: 2024100001688; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20240610

Effective date: 20240823

Free format text: TRIAL NUMBER: 2024100001687; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20240610

Effective date: 20240823

Free format text: TRIAL NUMBER: 2024100001686; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20240610

Effective date: 20240823

Free format text: TRIAL NUMBER: 2024100001685; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20240610

Effective date: 20240823

PJ1301 Trial decision

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20240610

Decision date: 20240823

Appeal identifier: 2024100001688

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20240610

Decision date: 20240823

Appeal identifier: 2024100001687

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20240610

Decision date: 20240823

Appeal identifier: 2024100001686

Patent event code: PJ13011S02D

Patent event date: 20240823

Comment text: Trial Decision for Confirmation of the Scope of a Right (Patent, Utility Model, Industrial Design)

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20240610

Decision date: 20240823

Appeal identifier: 2024100001685

J301 Trial decision

Free format text: TRIAL NUMBER: 2024100002157; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20240719

Effective date: 20240924

Free format text: TRIAL NUMBER: 2024100000947; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20240329

Effective date: 20240924

PJ1301 Trial decision

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20240719

Decision date: 20240924

Appeal identifier: 2024100002157

Patent event code: PJ13011S02D

Patent event date: 20240924

Comment text: Trial Decision for Confirmation of the Scope of a Right (Patent, Utility Model, Industrial Design)

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20240329

Decision date: 20240924

Appeal identifier: 2024100000947

J206 Request for trial to confirm the scope of a patent right
PJ0206 Trial to confirm the scope of a patent

Patent event code: PJ02062R01D

Patent event date: 20241018

Comment text: Request for Trial

Patent event code: PJ02061E01I

Patent event date: 20130327

Comment text: Registration of Establishment

Request date: 20241018

Appeal identifier: 2024100003027

Appeal kind category: Confirmation of the scope of right_defensive

J206 Request for trial to confirm the scope of a patent right
PJ0206 Trial to confirm the scope of a patent

Patent event code: PJ02062R01D

Patent event date: 20241105

Comment text: Request for Trial

Patent event code: PJ02061E01I

Patent event date: 20130327

Comment text: Registration of Establishment

Request date: 20241105

Appeal identifier: 2024100003196

Appeal kind category: Confirmation of the scope of right_defensive

J206 Request for trial to confirm the scope of a patent right
PJ0206 Trial to confirm the scope of a patent

Patent event code: PJ02062R01D

Patent event date: 20241224

Comment text: Request for Trial

Patent event code: PJ02061E01I

Patent event date: 20130327

Comment text: Registration of Establishment

Request date: 20241224

Appeal identifier: 2024100003707

Appeal kind category: Confirmation of the scope of right_defensive

J206 Request for trial to confirm the scope of a patent right
PJ0206 Trial to confirm the scope of a patent

Patent event code: PJ02062R01D

Patent event date: 20241230

Comment text: Request for Trial

Patent event code: PJ02061E01I

Patent event date: 20130327

Comment text: Registration of Establishment

Request date: 20241230

Appeal identifier: 2024100003750

Appeal kind category: Confirmation of the scope of right_defensive

J301 Trial decision

Free format text: TRIAL NUMBER: 2024100003196; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20241105

Effective date: 20250227

Free format text: TRIAL NUMBER: 2024100003027; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20241018

Effective date: 20250227

PJ1301 Trial decision

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20241105

Decision date: 20250227

Appeal identifier: 2024100003196

Patent event code: PJ13011S02D

Patent event date: 20250227

Comment text: Trial Decision for Confirmation of the Scope of a Right (Patent, Utility Model, Industrial Design)

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20241018

Decision date: 20250227

Appeal identifier: 2024100003027

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20241224

Decision date: 20250227

Appeal identifier: 2024100003707

J301 Trial decision

Free format text: TRIAL NUMBER: 2024100003750; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20241230

Effective date: 20250610

PJ1301 Trial decision

Patent event code: PJ13011S02D

Patent event date: 20250610

Comment text: Trial Decision for Confirmation of the Scope of a Right (Patent, Utility Model, Industrial Design)

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20241230

Decision date: 20250610

Appeal identifier: 2024100003750